JP2009536961A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009536961A5 JP2009536961A5 JP2009510340A JP2009510340A JP2009536961A5 JP 2009536961 A5 JP2009536961 A5 JP 2009536961A5 JP 2009510340 A JP2009510340 A JP 2009510340A JP 2009510340 A JP2009510340 A JP 2009510340A JP 2009536961 A5 JP2009536961 A5 JP 2009536961A5
- Authority
- JP
- Japan
- Prior art keywords
- ylamino
- methyl
- phenyl
- acid compound
- propanoic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 480
- -1 O— (C═O) Inorganic materials 0.000 claims 310
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 65
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 claims 54
- 235000019260 propionic acid Nutrition 0.000 claims 54
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims 46
- 239000002253 acid Substances 0.000 claims 46
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 45
- 201000010099 disease Diseases 0.000 claims 39
- 125000003118 aryl group Chemical group 0.000 claims 28
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 25
- 125000006413 ring segment Chemical group 0.000 claims 18
- 229910052739 hydrogen Inorganic materials 0.000 claims 15
- 239000001257 hydrogen Substances 0.000 claims 15
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 15
- 125000001424 substituent group Chemical group 0.000 claims 15
- 125000000217 alkyl group Chemical group 0.000 claims 13
- 102000006495 integrins Human genes 0.000 claims 12
- 108010044426 integrins Proteins 0.000 claims 12
- 206010016654 Fibrosis Diseases 0.000 claims 11
- 229910052757 nitrogen Inorganic materials 0.000 claims 11
- 229910052760 oxygen Inorganic materials 0.000 claims 11
- 125000003710 aryl alkyl group Chemical group 0.000 claims 10
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 10
- 230000004761 fibrosis Effects 0.000 claims 10
- 125000001072 heteroaryl group Chemical group 0.000 claims 10
- 125000005842 heteroatom Chemical group 0.000 claims 10
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 10
- 229910052717 sulfur Inorganic materials 0.000 claims 10
- 229910052736 halogen Inorganic materials 0.000 claims 8
- 150000002367 halogens Chemical class 0.000 claims 8
- 239000008194 pharmaceutical composition Substances 0.000 claims 8
- 125000003545 alkoxy group Chemical group 0.000 claims 7
- 125000004076 pyridyl group Chemical group 0.000 claims 7
- 125000003107 substituted aryl group Chemical group 0.000 claims 7
- 125000001544 thienyl group Chemical group 0.000 claims 7
- 206010028980 Neoplasm Diseases 0.000 claims 6
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 6
- 125000004432 carbon atom Chemical group C* 0.000 claims 6
- 125000004122 cyclic group Chemical group 0.000 claims 6
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims 6
- 208000035475 disorder Diseases 0.000 claims 6
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 6
- 125000000623 heterocyclic group Chemical group 0.000 claims 6
- 238000000034 method Methods 0.000 claims 6
- 125000000168 pyrrolyl group Chemical group 0.000 claims 6
- 125000000547 substituted alkyl group Chemical group 0.000 claims 6
- 238000011282 treatment Methods 0.000 claims 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 5
- 125000001153 fluoro group Chemical group F* 0.000 claims 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 5
- 125000002883 imidazolyl group Chemical group 0.000 claims 5
- 125000001786 isothiazolyl group Chemical group 0.000 claims 5
- 125000000842 isoxazolyl group Chemical group 0.000 claims 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 5
- 125000002971 oxazolyl group Chemical group 0.000 claims 5
- 125000003226 pyrazolyl group Chemical group 0.000 claims 5
- 125000000335 thiazolyl group Chemical group 0.000 claims 5
- 102000004190 Enzymes Human genes 0.000 claims 4
- 108090000790 Enzymes Proteins 0.000 claims 4
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 4
- 125000006350 alkyl thio alkyl group Chemical group 0.000 claims 4
- 201000011510 cancer Diseases 0.000 claims 4
- 210000004027 cell Anatomy 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 230000003176 fibrotic effect Effects 0.000 claims 4
- 125000002541 furyl group Chemical group 0.000 claims 4
- 125000004415 heterocyclylalkyl group Chemical group 0.000 claims 4
- 239000003446 ligand Substances 0.000 claims 4
- 125000001715 oxadiazolyl group Chemical group 0.000 claims 4
- 239000000126 substance Substances 0.000 claims 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 4
- 125000001113 thiadiazolyl group Chemical group 0.000 claims 4
- 125000001425 triazolyl group Chemical group 0.000 claims 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims 3
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims 3
- 206010018364 Glomerulonephritis Diseases 0.000 claims 3
- 206010034277 Pemphigoid Diseases 0.000 claims 3
- 201000004681 Psoriasis Diseases 0.000 claims 3
- 206010063837 Reperfusion injury Diseases 0.000 claims 3
- 125000003277 amino group Chemical group 0.000 claims 3
- 125000004429 atom Chemical group 0.000 claims 3
- 229910052799 carbon Inorganic materials 0.000 claims 3
- 238000001514 detection method Methods 0.000 claims 3
- 210000002744 extracellular matrix Anatomy 0.000 claims 3
- 208000015181 infectious disease Diseases 0.000 claims 3
- 230000003993 interaction Effects 0.000 claims 3
- 208000002780 macular degeneration Diseases 0.000 claims 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 3
- 125000004043 oxo group Chemical group O=* 0.000 claims 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 3
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 3
- 125000005415 substituted alkoxy group Chemical group 0.000 claims 3
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims 3
- 238000001356 surgical procedure Methods 0.000 claims 3
- 210000001519 tissue Anatomy 0.000 claims 3
- 238000002054 transplantation Methods 0.000 claims 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 3
- QZKZYBXYJFCIAM-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[5-[(1h-imidazol-2-ylamino)methyl]-1,3,4-oxadiazol-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC(CNC=3NC=CN=3)=NN=2)C=C1 QZKZYBXYJFCIAM-UHFFFAOYSA-N 0.000 claims 2
- VHGWTSKSCOCNJT-UHFFFAOYSA-N 2-ethyl-4-fluoro-6-methylbenzamide Chemical compound CCC1=CC(F)=CC(C)=C1C(N)=O VHGWTSKSCOCNJT-UHFFFAOYSA-N 0.000 claims 2
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims 2
- FNNZFWKITTVLLJ-UHFFFAOYSA-N 3-[4-[3-[(1h-benzimidazol-2-ylamino)methyl]-1,2,4-thiadiazol-5-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SN=C(CNC=3NC4=CC=CC=C4N=3)N=2)C=C1 FNNZFWKITTVLLJ-UHFFFAOYSA-N 0.000 claims 2
- MZWWGXAZLSDWQX-UHFFFAOYSA-N 3-[4-[3-[[(4-methoxypyridin-2-yl)amino]methyl]-1,2,4-thiadiazol-5-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound COC1=CC=NC(NCC=2N=C(SN=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 MZWWGXAZLSDWQX-UHFFFAOYSA-N 0.000 claims 2
- QHGMJKULBVCOQG-UHFFFAOYSA-N 3-[4-[3-[[(4-methylpyridin-2-yl)amino]methyl]-1,2,4-thiadiazol-5-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC=NC(NCC=2N=C(SN=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 QHGMJKULBVCOQG-UHFFFAOYSA-N 0.000 claims 2
- FYYUFQCXVFKYSI-UHFFFAOYSA-N 3-[4-[5-[(1h-benzimidazol-2-ylamino)methyl]-1,2,4-thiadiazol-3-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2N=C(CNC=3NC4=CC=CC=C4N=3)SN=2)C=C1 FYYUFQCXVFKYSI-UHFFFAOYSA-N 0.000 claims 2
- DWSRXQCHCCZBGS-UHFFFAOYSA-N 3-[4-[5-[(1h-benzimidazol-2-ylamino)methyl]-1,2,4-thiadiazol-3-yl]phenyl]-2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2N=C(CNC=3NC4=CC=CC=C4N=3)SN=2)C=C1 DWSRXQCHCCZBGS-UHFFFAOYSA-N 0.000 claims 2
- MXLUCHXRIQHKGW-UHFFFAOYSA-N 3-[4-[5-[(1h-benzimidazol-2-ylamino)methyl]-1,3,4-oxadiazol-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC(CNC=3NC4=CC=CC=C4N=3)=NN=2)C=C1 MXLUCHXRIQHKGW-UHFFFAOYSA-N 0.000 claims 2
- QZHPAEVAIUMSBA-UHFFFAOYSA-N 3-[4-[5-[(1h-benzimidazol-2-ylamino)methyl]-1,3,4-thiadiazol-2-yl]phenyl]-2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SC(CNC=3NC4=CC=CC=C4N=3)=NN=2)C=C1 QZHPAEVAIUMSBA-UHFFFAOYSA-N 0.000 claims 2
- SVVBXOJTEDDMOT-UHFFFAOYSA-N 3-[4-[5-[(1h-imidazol-2-ylamino)methyl]-1,3,4-oxadiazol-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC(CNC=3NC=CN=3)=NN=2)C=C1 SVVBXOJTEDDMOT-UHFFFAOYSA-N 0.000 claims 2
- ZRDNWGCQLVFDIM-UHFFFAOYSA-N 3-[4-[5-[[(4-methoxypyridin-2-yl)amino]methyl]-1,2,4-thiadiazol-3-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound COC1=CC=NC(NCC=2SN=C(N=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 ZRDNWGCQLVFDIM-UHFFFAOYSA-N 0.000 claims 2
- XBPPWCIXLWPQCG-UHFFFAOYSA-N 3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1,2,4-thiadiazol-3-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC=NC(NCC=2SN=C(N=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 XBPPWCIXLWPQCG-UHFFFAOYSA-N 0.000 claims 2
- YGPNNYSSAOOPGT-UHFFFAOYSA-N 3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1,3,4-oxadiazol-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC=NC(NCC=2OC(=NN=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 YGPNNYSSAOOPGT-UHFFFAOYSA-N 0.000 claims 2
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims 2
- 208000035473 Communicable disease Diseases 0.000 claims 2
- 208000011231 Crohn disease Diseases 0.000 claims 2
- 206010012689 Diabetic retinopathy Diseases 0.000 claims 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical class C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims 2
- 239000005977 Ethylene Substances 0.000 claims 2
- 208000010159 IgA glomerulonephritis Diseases 0.000 claims 2
- 206010021263 IgA nephropathy Diseases 0.000 claims 2
- 201000001263 Psoriatic Arthritis Diseases 0.000 claims 2
- 208000036824 Psoriatic arthropathy Diseases 0.000 claims 2
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 claims 2
- 206010039710 Scleroderma Diseases 0.000 claims 2
- 206010053648 Vascular occlusion Diseases 0.000 claims 2
- 208000009956 adenocarcinoma Diseases 0.000 claims 2
- 206010064930 age-related macular degeneration Diseases 0.000 claims 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 claims 2
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims 2
- 208000006673 asthma Diseases 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- 208000035269 cancer or benign tumor Diseases 0.000 claims 2
- 230000001684 chronic effect Effects 0.000 claims 2
- 230000000779 depleting effect Effects 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims 2
- 239000007850 fluorescent dye Substances 0.000 claims 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 2
- 201000011066 hemangioma Diseases 0.000 claims 2
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 2
- 238000003384 imaging method Methods 0.000 claims 2
- 150000002466 imines Chemical class 0.000 claims 2
- 208000027866 inflammatory disease Diseases 0.000 claims 2
- 239000003112 inhibitor Substances 0.000 claims 2
- 150000003951 lactams Chemical group 0.000 claims 2
- 210000004185 liver Anatomy 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- RIFHJAODNHLCBH-UHFFFAOYSA-N methanethione Chemical group S=[CH] RIFHJAODNHLCBH-UHFFFAOYSA-N 0.000 claims 2
- 125000004458 methylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])[H] 0.000 claims 2
- 210000005170 neoplastic cell Anatomy 0.000 claims 2
- 125000006574 non-aromatic ring group Chemical group 0.000 claims 2
- 201000008482 osteoarthritis Diseases 0.000 claims 2
- 230000005298 paramagnetic effect Effects 0.000 claims 2
- XUWHAWMETYGRKB-UHFFFAOYSA-N piperidin-2-one Chemical compound O=C1CCCCN1 XUWHAWMETYGRKB-UHFFFAOYSA-N 0.000 claims 2
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 claims 2
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 claims 2
- 201000000306 sarcoidosis Diseases 0.000 claims 2
- 239000000758 substrate Substances 0.000 claims 2
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 2
- 230000008685 targeting Effects 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- 230000007838 tissue remodeling Effects 0.000 claims 2
- 208000021331 vascular occlusion disease Diseases 0.000 claims 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 1
- 125000001399 1,2,3-triazolyl group Chemical group N1N=NC(=C1)* 0.000 claims 1
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 claims 1
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 claims 1
- CYKKKUOHKZGCLP-UHFFFAOYSA-N 2-[(1-methylcyclohexanecarbonyl)amino]-3-[4-[3-[[(4-methylpyridin-2-yl)amino]methyl]pyrrol-1-yl]phenyl]propanoic acid Chemical compound CC1=CC=NC(NCC2=CN(C=C2)C=2C=CC(CC(NC(=O)C3(C)CCCCC3)C(O)=O)=CC=2)=C1 CYKKKUOHKZGCLP-UHFFFAOYSA-N 0.000 claims 1
- GPJXMSKOVHYPGV-UHFFFAOYSA-N 2-[(1-methylcyclohexanecarbonyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1,3-thiazol-2-yl]phenyl]propanoic acid Chemical compound CC1=CC=NC(NCC=2SC(=NC=2)C=2C=CC(CC(NC(=O)C3(C)CCCCC3)C(O)=O)=CC=2)=C1 GPJXMSKOVHYPGV-UHFFFAOYSA-N 0.000 claims 1
- CVFHTVODGJKBRE-UHFFFAOYSA-N 2-[(2,6-dimethylbenzoyl)amino]-3-[4-[4-[[(4-methylpyridin-2-yl)amino]methyl]furan-2-yl]phenyl]propanoic acid Chemical compound CC1=CC=NC(NCC=2C=C(OC=2)C=2C=CC(CC(NC(=O)C=3C(=CC=CC=3C)C)C(O)=O)=CC=2)=C1 CVFHTVODGJKBRE-UHFFFAOYSA-N 0.000 claims 1
- POCSJOPFIYTNCZ-UHFFFAOYSA-N 2-[(2,6-dimethylbenzoyl)amino]-3-[4-[4-[[(4-methylpyridin-2-yl)amino]methyl]triazol-1-yl]phenyl]propanoic acid Chemical compound CC1=CC=NC(NCC=2N=NN(C=2)C=2C=CC(CC(NC(=O)C=3C(=CC=CC=3C)C)C(O)=O)=CC=2)=C1 POCSJOPFIYTNCZ-UHFFFAOYSA-N 0.000 claims 1
- DSBRVCRRGPAMJC-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[2-[[(4-methoxypyridin-2-yl)amino]methyl]-1h-imidazol-5-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2N=C(CNC=3N=CC=C(OC)C=3)NC=2)C=C1 DSBRVCRRGPAMJC-UHFFFAOYSA-N 0.000 claims 1
- MYBYFQDBBWDPFN-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[3-[(1h-imidazol-2-ylamino)methyl]-1,2,4-triazol-1-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(N2N=C(CNC=3NC=CN=3)N=C2)C=C1 MYBYFQDBBWDPFN-UHFFFAOYSA-N 0.000 claims 1
- CKRUKEHQIWEEIT-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[3-[[(4-methoxypyridin-2-yl)amino]methyl]-1,2-oxazol-5-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2ON=C(CNC=3N=CC=C(OC)C=3)C=2)C=C1 CKRUKEHQIWEEIT-UHFFFAOYSA-N 0.000 claims 1
- YFJAOUTXYMTPBL-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[3-[[(4-methoxypyridin-2-yl)amino]methyl]pyrazol-1-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(N2N=C(CNC=3N=CC=C(OC)C=3)C=C2)C=C1 YFJAOUTXYMTPBL-UHFFFAOYSA-N 0.000 claims 1
- VFCRZWKVLRWCJE-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[3-[[(4-methylpyridin-2-yl)amino]methyl]-1,2-thiazol-5-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SN=C(CNC=3N=CC=C(C)C=3)C=2)C=C1 VFCRZWKVLRWCJE-UHFFFAOYSA-N 0.000 claims 1
- KVOQVZDIDJXCMW-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[3-[[(4-methylpyridin-2-yl)amino]methyl]pyrazol-1-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(N2N=C(CNC=3N=CC=C(C)C=3)C=C2)C=C1 KVOQVZDIDJXCMW-UHFFFAOYSA-N 0.000 claims 1
- YWSIWWQDNLJYRQ-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[4-[(1h-imidazol-2-ylamino)methyl]triazol-1-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(N2N=NC(CNC=3NC=CN=3)=C2)C=C1 YWSIWWQDNLJYRQ-UHFFFAOYSA-N 0.000 claims 1
- WWDDVNSMIUYCPM-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[4-[[(4-methoxypyridin-2-yl)amino]methyl]-1,3-oxazol-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC=C(CNC=3N=CC=C(OC)C=3)N=2)C=C1 WWDDVNSMIUYCPM-UHFFFAOYSA-N 0.000 claims 1
- PYRKYTADJSMOSC-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[4-[[(4-methoxypyridin-2-yl)amino]methyl]pyrazol-1-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(N2N=CC(CNC=3N=CC=C(OC)C=3)=C2)C=C1 PYRKYTADJSMOSC-UHFFFAOYSA-N 0.000 claims 1
- JZNVXTFMWASSPL-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[4-[[(4-methoxypyridin-2-yl)amino]methyl]thiophen-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SC=C(CNC=3N=CC=C(OC)C=3)C=2)C=C1 JZNVXTFMWASSPL-UHFFFAOYSA-N 0.000 claims 1
- AMSRRIUKCBIGFW-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[4-[[(4-methylpyridin-2-yl)amino]methyl]-1,3-thiazol-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SC=C(CNC=3N=CC=C(C)C=3)N=2)C=C1 AMSRRIUKCBIGFW-UHFFFAOYSA-N 0.000 claims 1
- KUHFEKXVUCBSAJ-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[4-[[(4-methylpyridin-2-yl)amino]methyl]-1h-pyrrol-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2NC=C(CNC=3N=CC=C(C)C=3)C=2)C=C1 KUHFEKXVUCBSAJ-UHFFFAOYSA-N 0.000 claims 1
- UTMAWTBTTWPULL-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[4-[[(4-methylpyridin-2-yl)amino]methyl]furan-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC=C(CNC=3N=CC=C(C)C=3)C=2)C=C1 UTMAWTBTTWPULL-UHFFFAOYSA-N 0.000 claims 1
- WVLPMFPARVLOOF-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[4-[[(4-methylpyridin-2-yl)amino]methyl]thiophen-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SC=C(CNC=3N=CC=C(C)C=3)C=2)C=C1 WVLPMFPARVLOOF-UHFFFAOYSA-N 0.000 claims 1
- WRJCYTWDQSPKJG-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[5-[(1h-imidazol-2-ylamino)methyl]-1h-1,2,4-triazol-3-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2NC(CNC=3NC=CN=3)=NN=2)C=C1 WRJCYTWDQSPKJG-UHFFFAOYSA-N 0.000 claims 1
- VVXFYGQPHXLZDC-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methoxypyridin-2-yl)amino]methyl]-1,2-oxazol-3-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C2=NOC(CNC=3N=CC=C(OC)C=3)=C2)C=C1 VVXFYGQPHXLZDC-UHFFFAOYSA-N 0.000 claims 1
- WGDNIYXUVJQPRB-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methoxypyridin-2-yl)amino]methyl]-1,2-thiazol-3-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C2=NSC(CNC=3N=CC=C(OC)C=3)=C2)C=C1 WGDNIYXUVJQPRB-UHFFFAOYSA-N 0.000 claims 1
- FVCDRFGBCGZZFA-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methoxypyridin-2-yl)amino]methyl]-1,3-oxazol-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC(CNC=3N=CC=C(OC)C=3)=CN=2)C=C1 FVCDRFGBCGZZFA-UHFFFAOYSA-N 0.000 claims 1
- TZVULEHCCNRPCQ-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methoxypyridin-2-yl)amino]methyl]-1,3-thiazol-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SC(CNC=3N=CC=C(OC)C=3)=CN=2)C=C1 TZVULEHCCNRPCQ-UHFFFAOYSA-N 0.000 claims 1
- HEUYKMXYICJFDJ-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methoxypyridin-2-yl)amino]methyl]-1h-imidazol-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2NC(CNC=3N=CC=C(OC)C=3)=CN=2)C=C1 HEUYKMXYICJFDJ-UHFFFAOYSA-N 0.000 claims 1
- WLBZCCJZXRMNCH-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methoxypyridin-2-yl)amino]methyl]-1h-pyrrol-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2NC(CNC=3N=CC=C(OC)C=3)=CC=2)C=C1 WLBZCCJZXRMNCH-UHFFFAOYSA-N 0.000 claims 1
- LRANVQFNNGKOCH-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methoxypyridin-2-yl)amino]methyl]-1h-pyrrol-3-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2C=C(CNC=3N=CC=C(OC)C=3)NC=2)C=C1 LRANVQFNNGKOCH-UHFFFAOYSA-N 0.000 claims 1
- AFGOAZXSYHIPJD-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methoxypyridin-2-yl)amino]methyl]furan-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC(CNC=3N=CC=C(OC)C=3)=CC=2)C=C1 AFGOAZXSYHIPJD-UHFFFAOYSA-N 0.000 claims 1
- TWXBNYPIWJRXFU-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methoxypyridin-2-yl)amino]methyl]thiophen-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SC(CNC=3N=CC=C(OC)C=3)=CC=2)C=C1 TWXBNYPIWJRXFU-UHFFFAOYSA-N 0.000 claims 1
- INKXATIYWCYYEY-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1,2-thiazol-3-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C2=NSC(CNC=3N=CC=C(C)C=3)=C2)C=C1 INKXATIYWCYYEY-UHFFFAOYSA-N 0.000 claims 1
- OIGYWZJNJPLBMV-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1,3,4-oxadiazol-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC(CNC=3N=CC=C(C)C=3)=NN=2)C=C1 OIGYWZJNJPLBMV-UHFFFAOYSA-N 0.000 claims 1
- ACRSWTWNNAPOND-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1,3-oxazol-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC(CNC=3N=CC=C(C)C=3)=CN=2)C=C1 ACRSWTWNNAPOND-UHFFFAOYSA-N 0.000 claims 1
- DBPMFFNJNPTJNH-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1h-imidazol-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2NC(CNC=3N=CC=C(C)C=3)=CN=2)C=C1 DBPMFFNJNPTJNH-UHFFFAOYSA-N 0.000 claims 1
- QLPNKBHRLDXQAU-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1h-pyrrol-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2NC(CNC=3N=CC=C(C)C=3)=CC=2)C=C1 QLPNKBHRLDXQAU-UHFFFAOYSA-N 0.000 claims 1
- KTNCUWWKODNRMY-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1h-pyrrol-3-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2C=C(CNC=3N=CC=C(C)C=3)NC=2)C=C1 KTNCUWWKODNRMY-UHFFFAOYSA-N 0.000 claims 1
- FEERBSCTBCFGLM-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]furan-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC(CNC=3N=CC=C(C)C=3)=CC=2)C=C1 FEERBSCTBCFGLM-UHFFFAOYSA-N 0.000 claims 1
- MWBWJZHXKWCUKR-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]furan-3-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2C=C(CNC=3N=CC=C(C)C=3)OC=2)C=C1 MWBWJZHXKWCUKR-UHFFFAOYSA-N 0.000 claims 1
- XYFOAGAUEZPRIO-UHFFFAOYSA-N 2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]thiophen-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SC(CNC=3N=CC=C(C)C=3)=CC=2)C=C1 XYFOAGAUEZPRIO-UHFFFAOYSA-N 0.000 claims 1
- PPKIJWMXOIQIAO-UHFFFAOYSA-N 2-[(2-ethyl-6-methylbenzoyl)amino]-3-[4-[4-[[(4-methylpyridin-2-yl)amino]methyl]furan-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC=C(CNC=3N=CC=C(C)C=3)C=2)C=C1 PPKIJWMXOIQIAO-UHFFFAOYSA-N 0.000 claims 1
- XYAPQCFDZCQNLY-UHFFFAOYSA-N 2-[(2-ethyl-6-methylbenzoyl)amino]-3-[4-[4-[[(4-methylpyridin-2-yl)amino]methyl]triazol-1-yl]phenyl]propanoic acid Chemical compound CCC1=CC=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(N2N=NC(CNC=3N=CC=C(C)C=3)=C2)C=C1 XYAPQCFDZCQNLY-UHFFFAOYSA-N 0.000 claims 1
- JLAVTDCZFBCJOM-UHFFFAOYSA-N 2-[(4-chloro-2-ethyl-6-methylbenzoyl)amino]-3-[4-[2-[[(4-methylpyridin-2-yl)amino]methyl]-1,3-oxazol-4-yl]phenyl]propanoic acid Chemical compound CCC1=CC(Cl)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2N=C(CNC=3N=CC=C(C)C=3)OC=2)C=C1 JLAVTDCZFBCJOM-UHFFFAOYSA-N 0.000 claims 1
- NDMGMQOVXNUJFI-UHFFFAOYSA-N 2-[(4-chloro-2-ethyl-6-methylbenzoyl)amino]-3-[4-[2-[[(4-methylpyridin-2-yl)amino]methyl]-1,3-oxazol-5-yl]phenyl]propanoic acid Chemical compound CCC1=CC(Cl)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC(CNC=3N=CC=C(C)C=3)=NC=2)C=C1 NDMGMQOVXNUJFI-UHFFFAOYSA-N 0.000 claims 1
- XDBMWIGJQOGOKW-UHFFFAOYSA-N 2-[(4-chloro-2-ethyl-6-methylbenzoyl)amino]-3-[4-[2-[[(4-methylpyridin-2-yl)amino]methyl]-1,3-thiazol-4-yl]phenyl]propanoic acid Chemical compound CCC1=CC(Cl)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2N=C(CNC=3N=CC=C(C)C=3)SC=2)C=C1 XDBMWIGJQOGOKW-UHFFFAOYSA-N 0.000 claims 1
- BURRDVLGSYFZTI-UHFFFAOYSA-N 2-[(4-chloro-2-ethyl-6-methylbenzoyl)amino]-3-[4-[2-[[(4-methylpyridin-2-yl)amino]methyl]-1,3-thiazol-5-yl]phenyl]propanoic acid Chemical compound CCC1=CC(Cl)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SC(CNC=3N=CC=C(C)C=3)=NC=2)C=C1 BURRDVLGSYFZTI-UHFFFAOYSA-N 0.000 claims 1
- FKQWISITIQMWQR-UHFFFAOYSA-N 2-[(4-chloro-2-ethyl-6-methylbenzoyl)amino]-3-[4-[3-[[(4-methylpyridin-2-yl)amino]methyl]-1,2,4-thiadiazol-5-yl]phenyl]propanoic acid Chemical compound CCC1=CC(Cl)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SN=C(CNC=3N=CC=C(C)C=3)N=2)C=C1 FKQWISITIQMWQR-UHFFFAOYSA-N 0.000 claims 1
- FQQIVRVGUZQGQT-UHFFFAOYSA-N 2-[(4-chloro-2-ethyl-6-methylbenzoyl)amino]-3-[4-[3-[[(4-methylpyridin-2-yl)amino]methyl]-1,2,4-triazol-1-yl]phenyl]propanoic acid Chemical compound CCC1=CC(Cl)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(N2N=C(CNC=3N=CC=C(C)C=3)N=C2)C=C1 FQQIVRVGUZQGQT-UHFFFAOYSA-N 0.000 claims 1
- ZGGNMBDKCKEYDY-UHFFFAOYSA-N 2-[(4-chloro-2-ethyl-6-methylbenzoyl)amino]-3-[4-[3-[[(4-methylpyridin-2-yl)amino]methyl]-1,2-oxazol-5-yl]phenyl]propanoic acid Chemical compound CCC1=CC(Cl)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2ON=C(CNC=3N=CC=C(C)C=3)C=2)C=C1 ZGGNMBDKCKEYDY-UHFFFAOYSA-N 0.000 claims 1
- UGWBONLGKFXAEW-UHFFFAOYSA-N 2-[(4-chloro-2-ethyl-6-methylbenzoyl)amino]-3-[4-[3-[[(4-methylpyridin-2-yl)amino]methyl]-1,2-thiazol-5-yl]phenyl]propanoic acid Chemical compound CCC1=CC(Cl)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SN=C(CNC=3N=CC=C(C)C=3)C=2)C=C1 UGWBONLGKFXAEW-UHFFFAOYSA-N 0.000 claims 1
- QRBPXWGKFWZDJU-UHFFFAOYSA-N 2-[(4-chloro-2-ethyl-6-methylbenzoyl)amino]-3-[4-[3-[[(4-methylpyridin-2-yl)amino]methyl]pyrazol-1-yl]phenyl]propanoic acid Chemical compound CCC1=CC(Cl)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(N2N=C(CNC=3N=CC=C(C)C=3)C=C2)C=C1 QRBPXWGKFWZDJU-UHFFFAOYSA-N 0.000 claims 1
- ZAYFXXSLSNKSAW-UHFFFAOYSA-N 2-[(4-chloro-2-ethyl-6-methylbenzoyl)amino]-3-[4-[3-[[(4-methylpyridin-2-yl)amino]methyl]pyrrol-1-yl]phenyl]propanoic acid Chemical compound CCC1=CC(Cl)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(N2C=C(CNC=3N=CC=C(C)C=3)C=C2)C=C1 ZAYFXXSLSNKSAW-UHFFFAOYSA-N 0.000 claims 1
- AKGKZXKIWQIYBG-UHFFFAOYSA-N 2-[(4-chloro-2-ethyl-6-methylbenzoyl)amino]-3-[4-[4-[[(4-methylpyridin-2-yl)amino]methyl]-1,3-oxazol-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(Cl)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC=C(CNC=3N=CC=C(C)C=3)N=2)C=C1 AKGKZXKIWQIYBG-UHFFFAOYSA-N 0.000 claims 1
- QQTBCAABZXMBJE-UHFFFAOYSA-N 2-[(4-chloro-2-ethyl-6-methylbenzoyl)amino]-3-[4-[4-[[(4-methylpyridin-2-yl)amino]methyl]-1,3-thiazol-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(Cl)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SC=C(CNC=3N=CC=C(C)C=3)N=2)C=C1 QQTBCAABZXMBJE-UHFFFAOYSA-N 0.000 claims 1
- RUJUMVCCCKDCOZ-UHFFFAOYSA-N 2-[(4-chloro-2-ethyl-6-methylbenzoyl)amino]-3-[4-[4-[[(4-methylpyridin-2-yl)amino]methyl]-1h-pyrrol-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(Cl)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2NC=C(CNC=3N=CC=C(C)C=3)C=2)C=C1 RUJUMVCCCKDCOZ-UHFFFAOYSA-N 0.000 claims 1
- FJHPVYGJXVHDDO-UHFFFAOYSA-N 2-[(4-chloro-2-ethyl-6-methylbenzoyl)amino]-3-[4-[4-[[(4-methylpyridin-2-yl)amino]methyl]furan-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(Cl)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC=C(CNC=3N=CC=C(C)C=3)C=2)C=C1 FJHPVYGJXVHDDO-UHFFFAOYSA-N 0.000 claims 1
- YFAMQXFXLAXMMT-UHFFFAOYSA-N 2-[(4-chloro-2-ethyl-6-methylbenzoyl)amino]-3-[4-[4-[[(4-methylpyridin-2-yl)amino]methyl]imidazol-1-yl]phenyl]propanoic acid Chemical compound CCC1=CC(Cl)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(N2C=C(CNC=3N=CC=C(C)C=3)N=C2)C=C1 YFAMQXFXLAXMMT-UHFFFAOYSA-N 0.000 claims 1
- MTJGFXMSBVOPNL-UHFFFAOYSA-N 2-[(4-chloro-2-ethyl-6-methylbenzoyl)amino]-3-[4-[4-[[(4-methylpyridin-2-yl)amino]methyl]thiophen-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(Cl)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SC=C(CNC=3N=CC=C(C)C=3)C=2)C=C1 MTJGFXMSBVOPNL-UHFFFAOYSA-N 0.000 claims 1
- PQIZTGGBHVCXES-UHFFFAOYSA-N 2-[(4-chloro-2-ethyl-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1,2,4-thiadiazol-3-yl]phenyl]propanoic acid Chemical compound CCC1=CC(Cl)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2N=C(CNC=3N=CC=C(C)C=3)SN=2)C=C1 PQIZTGGBHVCXES-UHFFFAOYSA-N 0.000 claims 1
- AQVGJWXQQXBRGR-UHFFFAOYSA-N 2-[(4-chloro-2-ethyl-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1,2-oxazol-3-yl]phenyl]propanoic acid Chemical compound CCC1=CC(Cl)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C2=NOC(CNC=3N=CC=C(C)C=3)=C2)C=C1 AQVGJWXQQXBRGR-UHFFFAOYSA-N 0.000 claims 1
- LKKWEJSJAZHEIG-UHFFFAOYSA-N 2-[(4-chloro-2-ethyl-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1,2-thiazol-3-yl]phenyl]propanoic acid Chemical compound CCC1=CC(Cl)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C2=NSC(CNC=3N=CC=C(C)C=3)=C2)C=C1 LKKWEJSJAZHEIG-UHFFFAOYSA-N 0.000 claims 1
- KBZJAEZRTBJYFK-UHFFFAOYSA-N 2-[(4-chloro-2-ethyl-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1,3,4-oxadiazol-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(Cl)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC(CNC=3N=CC=C(C)C=3)=NN=2)C=C1 KBZJAEZRTBJYFK-UHFFFAOYSA-N 0.000 claims 1
- LQJWLDDPWSIXJV-UHFFFAOYSA-N 2-[(4-chloro-2-ethyl-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1,3-oxazol-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(Cl)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC(CNC=3N=CC=C(C)C=3)=CN=2)C=C1 LQJWLDDPWSIXJV-UHFFFAOYSA-N 0.000 claims 1
- JUJDYTLWNQGSPQ-UHFFFAOYSA-N 2-[(4-chloro-2-ethyl-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1,3-thiazol-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(Cl)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SC(CNC=3N=CC=C(C)C=3)=CN=2)C=C1 JUJDYTLWNQGSPQ-UHFFFAOYSA-N 0.000 claims 1
- SJUPXZJEKUDOSR-UHFFFAOYSA-N 2-[(4-chloro-2-ethyl-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1h-pyrrol-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(Cl)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2NC(CNC=3N=CC=C(C)C=3)=CC=2)C=C1 SJUPXZJEKUDOSR-UHFFFAOYSA-N 0.000 claims 1
- ZKIJUVUGMSOHAS-UHFFFAOYSA-N 2-[(4-chloro-2-ethyl-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1h-pyrrol-3-yl]phenyl]propanoic acid Chemical compound CCC1=CC(Cl)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2C=C(CNC=3N=CC=C(C)C=3)NC=2)C=C1 ZKIJUVUGMSOHAS-UHFFFAOYSA-N 0.000 claims 1
- NOIVJJYDQSUNLF-UHFFFAOYSA-N 2-[(4-chloro-2-ethyl-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]furan-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(Cl)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC(CNC=3N=CC=C(C)C=3)=CC=2)C=C1 NOIVJJYDQSUNLF-UHFFFAOYSA-N 0.000 claims 1
- VFWLORRYQURCMS-UHFFFAOYSA-N 2-[(4-chloro-2-ethyl-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]furan-3-yl]phenyl]propanoic acid Chemical compound CCC1=CC(Cl)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2C=C(CNC=3N=CC=C(C)C=3)OC=2)C=C1 VFWLORRYQURCMS-UHFFFAOYSA-N 0.000 claims 1
- NEJAGXCFZNKOPH-UHFFFAOYSA-N 2-[(4-chloro-2-ethyl-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]thiophen-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(Cl)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SC(CNC=3N=CC=C(C)C=3)=CC=2)C=C1 NEJAGXCFZNKOPH-UHFFFAOYSA-N 0.000 claims 1
- LGLMYOHMUBFNMV-UHFFFAOYSA-N 2-[(4-chloro-2-ethyl-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]thiophen-3-yl]phenyl]propanoic acid Chemical compound CCC1=CC(Cl)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2C=C(CNC=3N=CC=C(C)C=3)SC=2)C=C1 LGLMYOHMUBFNMV-UHFFFAOYSA-N 0.000 claims 1
- LZHHAZCKXRTBCG-UHFFFAOYSA-N 2-[(4-cyano-2-ethyl-6-methylbenzoyl)amino]-3-[4-[2-[[(4-methylpyridin-2-yl)amino]methyl]-1,3-oxazol-4-yl]phenyl]propanoic acid Chemical compound CCC1=CC(C#N)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2N=C(CNC=3N=CC=C(C)C=3)OC=2)C=C1 LZHHAZCKXRTBCG-UHFFFAOYSA-N 0.000 claims 1
- GEABKGZBQJVTEM-UHFFFAOYSA-N 2-[(4-cyano-2-ethyl-6-methylbenzoyl)amino]-3-[4-[2-[[(4-methylpyridin-2-yl)amino]methyl]-1,3-oxazol-5-yl]phenyl]propanoic acid Chemical compound CCC1=CC(C#N)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC(CNC=3N=CC=C(C)C=3)=NC=2)C=C1 GEABKGZBQJVTEM-UHFFFAOYSA-N 0.000 claims 1
- OFSJNGKAQSZZHR-UHFFFAOYSA-N 2-[(4-cyano-2-ethyl-6-methylbenzoyl)amino]-3-[4-[2-[[(4-methylpyridin-2-yl)amino]methyl]-1,3-thiazol-4-yl]phenyl]propanoic acid Chemical compound CCC1=CC(C#N)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2N=C(CNC=3N=CC=C(C)C=3)SC=2)C=C1 OFSJNGKAQSZZHR-UHFFFAOYSA-N 0.000 claims 1
- FXCJUOFBNVVMIF-UHFFFAOYSA-N 2-[(4-cyano-2-ethyl-6-methylbenzoyl)amino]-3-[4-[2-[[(4-methylpyridin-2-yl)amino]methyl]-1,3-thiazol-5-yl]phenyl]propanoic acid Chemical compound CCC1=CC(C#N)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SC(CNC=3N=CC=C(C)C=3)=NC=2)C=C1 FXCJUOFBNVVMIF-UHFFFAOYSA-N 0.000 claims 1
- KCQXGPNBQBSAIX-UHFFFAOYSA-N 2-[(4-cyano-2-ethyl-6-methylbenzoyl)amino]-3-[4-[3-[[(4-methylpyridin-2-yl)amino]methyl]-1,2,4-thiadiazol-5-yl]phenyl]propanoic acid Chemical compound CCC1=CC(C#N)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SN=C(CNC=3N=CC=C(C)C=3)N=2)C=C1 KCQXGPNBQBSAIX-UHFFFAOYSA-N 0.000 claims 1
- AWAOIMZJVYQVFR-UHFFFAOYSA-N 2-[(4-cyano-2-ethyl-6-methylbenzoyl)amino]-3-[4-[3-[[(4-methylpyridin-2-yl)amino]methyl]-1,2,4-triazol-1-yl]phenyl]propanoic acid Chemical compound CCC1=CC(C#N)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(N2N=C(CNC=3N=CC=C(C)C=3)N=C2)C=C1 AWAOIMZJVYQVFR-UHFFFAOYSA-N 0.000 claims 1
- CLTQLGXBNLALEZ-UHFFFAOYSA-N 2-[(4-cyano-2-ethyl-6-methylbenzoyl)amino]-3-[4-[3-[[(4-methylpyridin-2-yl)amino]methyl]-1,2-oxazol-5-yl]phenyl]propanoic acid Chemical compound CCC1=CC(C#N)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2ON=C(CNC=3N=CC=C(C)C=3)C=2)C=C1 CLTQLGXBNLALEZ-UHFFFAOYSA-N 0.000 claims 1
- QJCBHWZMXZGHPX-UHFFFAOYSA-N 2-[(4-cyano-2-ethyl-6-methylbenzoyl)amino]-3-[4-[3-[[(4-methylpyridin-2-yl)amino]methyl]-1,2-thiazol-5-yl]phenyl]propanoic acid Chemical compound CCC1=CC(C#N)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SN=C(CNC=3N=CC=C(C)C=3)C=2)C=C1 QJCBHWZMXZGHPX-UHFFFAOYSA-N 0.000 claims 1
- CBUJFZWUTQSPIH-UHFFFAOYSA-N 2-[(4-cyano-2-ethyl-6-methylbenzoyl)amino]-3-[4-[3-[[(4-methylpyridin-2-yl)amino]methyl]pyrazol-1-yl]phenyl]propanoic acid Chemical compound CCC1=CC(C#N)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(N2N=C(CNC=3N=CC=C(C)C=3)C=C2)C=C1 CBUJFZWUTQSPIH-UHFFFAOYSA-N 0.000 claims 1
- XUIOOTBGFKMRAZ-UHFFFAOYSA-N 2-[(4-cyano-2-ethyl-6-methylbenzoyl)amino]-3-[4-[4-[[(4-methylpyridin-2-yl)amino]methyl]-1,3-oxazol-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(C#N)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC=C(CNC=3N=CC=C(C)C=3)N=2)C=C1 XUIOOTBGFKMRAZ-UHFFFAOYSA-N 0.000 claims 1
- NGUUJGDFILFGFW-UHFFFAOYSA-N 2-[(4-cyano-2-ethyl-6-methylbenzoyl)amino]-3-[4-[4-[[(4-methylpyridin-2-yl)amino]methyl]-1,3-thiazol-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(C#N)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SC=C(CNC=3N=CC=C(C)C=3)N=2)C=C1 NGUUJGDFILFGFW-UHFFFAOYSA-N 0.000 claims 1
- VQVVMGLRRXRVQA-UHFFFAOYSA-N 2-[(4-cyano-2-ethyl-6-methylbenzoyl)amino]-3-[4-[4-[[(4-methylpyridin-2-yl)amino]methyl]furan-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(C#N)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC=C(CNC=3N=CC=C(C)C=3)C=2)C=C1 VQVVMGLRRXRVQA-UHFFFAOYSA-N 0.000 claims 1
- SFEJFXZBMKQSDB-UHFFFAOYSA-N 2-[(4-cyano-2-ethyl-6-methylbenzoyl)amino]-3-[4-[4-[[(4-methylpyridin-2-yl)amino]methyl]imidazol-1-yl]phenyl]propanoic acid Chemical compound CCC1=CC(C#N)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(N2C=C(CNC=3N=CC=C(C)C=3)N=C2)C=C1 SFEJFXZBMKQSDB-UHFFFAOYSA-N 0.000 claims 1
- MNAXKDKLDMYLMD-UHFFFAOYSA-N 2-[(4-cyano-2-ethyl-6-methylbenzoyl)amino]-3-[4-[4-[[(4-methylpyridin-2-yl)amino]methyl]thiophen-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(C#N)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SC=C(CNC=3N=CC=C(C)C=3)C=2)C=C1 MNAXKDKLDMYLMD-UHFFFAOYSA-N 0.000 claims 1
- UKSWIWFPQRTVCH-UHFFFAOYSA-N 2-[(4-cyano-2-ethyl-6-methylbenzoyl)amino]-3-[4-[4-[[(4-methylpyridin-2-yl)amino]methyl]triazol-1-yl]phenyl]propanoic acid Chemical compound CCC1=CC(C#N)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(N2N=NC(CNC=3N=CC=C(C)C=3)=C2)C=C1 UKSWIWFPQRTVCH-UHFFFAOYSA-N 0.000 claims 1
- PNYBZXSSPKURIS-UHFFFAOYSA-N 2-[(4-cyano-2-ethyl-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1,2,4-thiadiazol-3-yl]phenyl]propanoic acid Chemical compound CCC1=CC(C#N)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2N=C(CNC=3N=CC=C(C)C=3)SN=2)C=C1 PNYBZXSSPKURIS-UHFFFAOYSA-N 0.000 claims 1
- MUPJJYRPMYDSQC-UHFFFAOYSA-N 2-[(4-cyano-2-ethyl-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1,2-oxazol-3-yl]phenyl]propanoic acid Chemical compound CCC1=CC(C#N)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C2=NOC(CNC=3N=CC=C(C)C=3)=C2)C=C1 MUPJJYRPMYDSQC-UHFFFAOYSA-N 0.000 claims 1
- SVHMIPRZUQAHSA-UHFFFAOYSA-N 2-[(4-cyano-2-ethyl-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1,2-thiazol-3-yl]phenyl]propanoic acid Chemical compound CCC1=CC(C#N)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C2=NSC(CNC=3N=CC=C(C)C=3)=C2)C=C1 SVHMIPRZUQAHSA-UHFFFAOYSA-N 0.000 claims 1
- HMAOKQJUNFBBEL-UHFFFAOYSA-N 2-[(4-cyano-2-ethyl-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1,3,4-oxadiazol-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(C#N)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC(CNC=3N=CC=C(C)C=3)=NN=2)C=C1 HMAOKQJUNFBBEL-UHFFFAOYSA-N 0.000 claims 1
- HTGXIEVJYGNTAJ-UHFFFAOYSA-N 2-[(4-cyano-2-ethyl-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1,3,4-thiadiazol-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(C#N)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SC(CNC=3N=CC=C(C)C=3)=NN=2)C=C1 HTGXIEVJYGNTAJ-UHFFFAOYSA-N 0.000 claims 1
- UNRAGJHYTLZVGX-UHFFFAOYSA-N 2-[(4-cyano-2-ethyl-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1,3-oxazol-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(C#N)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC(CNC=3N=CC=C(C)C=3)=CN=2)C=C1 UNRAGJHYTLZVGX-UHFFFAOYSA-N 0.000 claims 1
- QBCLRGIXESABDF-UHFFFAOYSA-N 2-[(4-cyano-2-ethyl-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1,3-thiazol-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(C#N)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SC(CNC=3N=CC=C(C)C=3)=CN=2)C=C1 QBCLRGIXESABDF-UHFFFAOYSA-N 0.000 claims 1
- ZNIQZHBGLINOLE-UHFFFAOYSA-N 2-[(4-cyano-2-ethyl-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1h-pyrrol-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(C#N)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2NC(CNC=3N=CC=C(C)C=3)=CC=2)C=C1 ZNIQZHBGLINOLE-UHFFFAOYSA-N 0.000 claims 1
- VRWURWVAHABBPR-UHFFFAOYSA-N 2-[(4-cyano-2-ethyl-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1h-pyrrol-3-yl]phenyl]propanoic acid Chemical compound CCC1=CC(C#N)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2C=C(CNC=3N=CC=C(C)C=3)NC=2)C=C1 VRWURWVAHABBPR-UHFFFAOYSA-N 0.000 claims 1
- PEZXIDNZPFIQNE-UHFFFAOYSA-N 2-[(4-cyano-2-ethyl-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]furan-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(C#N)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC(CNC=3N=CC=C(C)C=3)=CC=2)C=C1 PEZXIDNZPFIQNE-UHFFFAOYSA-N 0.000 claims 1
- NZFMBKCFRLPHIX-UHFFFAOYSA-N 2-[(4-cyano-2-ethyl-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]furan-3-yl]phenyl]propanoic acid Chemical compound CCC1=CC(C#N)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2C=C(CNC=3N=CC=C(C)C=3)OC=2)C=C1 NZFMBKCFRLPHIX-UHFFFAOYSA-N 0.000 claims 1
- QNGJKRRQSALHPI-UHFFFAOYSA-N 2-[(4-cyano-2-ethyl-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]thiophen-2-yl]phenyl]propanoic acid Chemical compound CCC1=CC(C#N)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SC(CNC=3N=CC=C(C)C=3)=CC=2)C=C1 QNGJKRRQSALHPI-UHFFFAOYSA-N 0.000 claims 1
- KESGQBXBYDBBAE-UHFFFAOYSA-N 2-[(4-cyano-2-ethyl-6-methylbenzoyl)amino]-3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]thiophen-3-yl]phenyl]propanoic acid Chemical compound CCC1=CC(C#N)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2C=C(CNC=3N=CC=C(C)C=3)SC=2)C=C1 KESGQBXBYDBBAE-UHFFFAOYSA-N 0.000 claims 1
- GMCJIDOHCIKPRJ-UHFFFAOYSA-N 2-[(4-fluoro-2,6-dimethylbenzoyl)amino]-3-[4-[4-[[(4-methylpyridin-2-yl)amino]methyl]furan-2-yl]phenyl]propanoic acid Chemical compound CC1=CC=NC(NCC=2C=C(OC=2)C=2C=CC(CC(NC(=O)C=3C(=CC(F)=CC=3C)C)C(O)=O)=CC=2)=C1 GMCJIDOHCIKPRJ-UHFFFAOYSA-N 0.000 claims 1
- RXGKXEXMRNEZHO-UHFFFAOYSA-N 2-[(4-fluoro-2,6-dimethylbenzoyl)amino]-3-[4-[4-[[(4-methylpyridin-2-yl)amino]methyl]triazol-1-yl]phenyl]propanoic acid Chemical compound CC1=CC=NC(NCC=2N=NN(C=2)C=2C=CC(CC(NC(=O)C=3C(=CC(F)=CC=3C)C)C(O)=O)=CC=2)=C1 RXGKXEXMRNEZHO-UHFFFAOYSA-N 0.000 claims 1
- ZZGHWYIEKZDGFX-UHFFFAOYSA-N 3-[4-[2-[(1h-imidazol-2-ylamino)methyl]-1,3-oxazol-4-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2N=C(CNC=3NC=CN=3)OC=2)C=C1 ZZGHWYIEKZDGFX-UHFFFAOYSA-N 0.000 claims 1
- BBOZWJWPSUOIGG-UHFFFAOYSA-N 3-[4-[2-[(1h-imidazol-2-ylamino)methyl]-1,3-oxazol-5-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC(CNC=3NC=CN=3)=NC=2)C=C1 BBOZWJWPSUOIGG-UHFFFAOYSA-N 0.000 claims 1
- LOZSZXVYTNHOKC-UHFFFAOYSA-N 3-[4-[2-[(1h-imidazol-2-ylamino)methyl]-1,3-thiazol-4-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2N=C(CNC=3NC=CN=3)SC=2)C=C1 LOZSZXVYTNHOKC-UHFFFAOYSA-N 0.000 claims 1
- LXZIIGOLDAIMKG-UHFFFAOYSA-N 3-[4-[2-[(1h-imidazol-2-ylamino)methyl]-1,3-thiazol-5-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SC(CNC=3NC=CN=3)=NC=2)C=C1 LXZIIGOLDAIMKG-UHFFFAOYSA-N 0.000 claims 1
- AQHDVVNPKIHQEE-UHFFFAOYSA-N 3-[4-[2-[(1h-imidazol-2-ylamino)methyl]-1h-imidazol-5-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2N=C(CNC=3NC=CN=3)NC=2)C=C1 AQHDVVNPKIHQEE-UHFFFAOYSA-N 0.000 claims 1
- AZGNFAFIGSHOOD-UHFFFAOYSA-N 3-[4-[2-[[(4-methoxypyridin-2-yl)amino]methyl]-1,3-oxazol-4-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound COC1=CC=NC(NCC=2OC=C(N=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 AZGNFAFIGSHOOD-UHFFFAOYSA-N 0.000 claims 1
- SYMNEXZFDXMTAX-UHFFFAOYSA-N 3-[4-[2-[[(4-methoxypyridin-2-yl)amino]methyl]-1,3-oxazol-5-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound COC1=CC=NC(NCC=2OC(=CN=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 SYMNEXZFDXMTAX-UHFFFAOYSA-N 0.000 claims 1
- HKIWULZYOJPPKK-UHFFFAOYSA-N 3-[4-[2-[[(4-methoxypyridin-2-yl)amino]methyl]-1,3-thiazol-4-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound COC1=CC=NC(NCC=2SC=C(N=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 HKIWULZYOJPPKK-UHFFFAOYSA-N 0.000 claims 1
- SJPJMRFEQBLQSA-UHFFFAOYSA-N 3-[4-[2-[[(4-methoxypyridin-2-yl)amino]methyl]-1,3-thiazol-5-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound COC1=CC=NC(NCC=2SC(=CN=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 SJPJMRFEQBLQSA-UHFFFAOYSA-N 0.000 claims 1
- JAZRVZBIIFBWBK-UHFFFAOYSA-N 3-[4-[2-[[(4-methylpyridin-2-yl)amino]methyl]-1,3-oxazol-4-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC=NC(NCC=2OC=C(N=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 JAZRVZBIIFBWBK-UHFFFAOYSA-N 0.000 claims 1
- IMQOIMKCENQJPI-UHFFFAOYSA-N 3-[4-[2-[[(4-methylpyridin-2-yl)amino]methyl]-1,3-oxazol-5-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC=NC(NCC=2OC(=CN=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 IMQOIMKCENQJPI-UHFFFAOYSA-N 0.000 claims 1
- DJWGWKWBCVSVPK-UHFFFAOYSA-N 3-[4-[2-[[(4-methylpyridin-2-yl)amino]methyl]-1,3-thiazol-4-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC=NC(NCC=2SC=C(N=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 DJWGWKWBCVSVPK-UHFFFAOYSA-N 0.000 claims 1
- KOEIHNQIADMVQW-UHFFFAOYSA-N 3-[4-[2-[[(4-methylpyridin-2-yl)amino]methyl]-1,3-thiazol-5-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC=NC(NCC=2SC(=CN=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 KOEIHNQIADMVQW-UHFFFAOYSA-N 0.000 claims 1
- YWWFKFLJKKUHLA-UHFFFAOYSA-N 3-[4-[3-[(1h-benzimidazol-2-ylamino)methyl]-1,2,4-triazol-1-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(N2N=C(CNC=3NC4=CC=CC=C4N=3)N=C2)C=C1 YWWFKFLJKKUHLA-UHFFFAOYSA-N 0.000 claims 1
- CUVYCHLYIJVYBF-UHFFFAOYSA-N 3-[4-[3-[(1h-benzimidazol-2-ylamino)methyl]-1,2,4-triazol-1-yl]phenyl]-2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(N2N=C(CNC=3NC4=CC=CC=C4N=3)N=C2)C=C1 CUVYCHLYIJVYBF-UHFFFAOYSA-N 0.000 claims 1
- IPCLVKCIMWPHSI-UHFFFAOYSA-N 3-[4-[3-[(1h-imidazol-2-ylamino)methyl]-1,2,4-triazol-1-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(N2N=C(CNC=3NC=CN=3)N=C2)C=C1 IPCLVKCIMWPHSI-UHFFFAOYSA-N 0.000 claims 1
- FMCQYUNUYUNWIV-UHFFFAOYSA-N 3-[4-[3-[(1h-imidazol-2-ylamino)methyl]-1,2-oxazol-5-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2ON=C(CNC=3NC=CN=3)C=2)C=C1 FMCQYUNUYUNWIV-UHFFFAOYSA-N 0.000 claims 1
- JMQODZNTMNQLAT-UHFFFAOYSA-N 3-[4-[3-[(1h-imidazol-2-ylamino)methyl]-1,2-thiazol-5-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SN=C(CNC=3NC=CN=3)C=2)C=C1 JMQODZNTMNQLAT-UHFFFAOYSA-N 0.000 claims 1
- NBICOZJQTRKKLI-UHFFFAOYSA-N 3-[4-[3-[(1h-imidazol-2-ylamino)methyl]pyrazol-1-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(N2N=C(CNC=3NC=CN=3)C=C2)C=C1 NBICOZJQTRKKLI-UHFFFAOYSA-N 0.000 claims 1
- VLBFQDOUULQTBZ-UHFFFAOYSA-N 3-[4-[3-[[(4-methoxypyridin-2-yl)amino]methyl]-1,2-oxazol-5-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound COC1=CC=NC(NCC2=NOC(=C2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 VLBFQDOUULQTBZ-UHFFFAOYSA-N 0.000 claims 1
- PYEUFTUGRVIFNF-UHFFFAOYSA-N 3-[4-[3-[[(4-methoxypyridin-2-yl)amino]methyl]-1,2-thiazol-5-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound COC1=CC=NC(NCC2=NSC(=C2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 PYEUFTUGRVIFNF-UHFFFAOYSA-N 0.000 claims 1
- XRIHUZYLIIDSBZ-UHFFFAOYSA-N 3-[4-[3-[[(4-methylpyridin-2-yl)amino]methyl]-1,2-oxazol-5-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC=NC(NCC2=NOC(=C2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 XRIHUZYLIIDSBZ-UHFFFAOYSA-N 0.000 claims 1
- PEIFIJHWDMOEFY-UHFFFAOYSA-N 3-[4-[3-[[(4-methylpyridin-2-yl)amino]methyl]-1,2-thiazol-5-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC=NC(NCC2=NSC(=C2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 PEIFIJHWDMOEFY-UHFFFAOYSA-N 0.000 claims 1
- HXKJQECTXPNISX-UHFFFAOYSA-N 3-[4-[4-[(1,2-oxazol-3-ylamino)methyl]triazol-1-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(N2N=NC(CNC3=NOC=C3)=C2)C=C1 HXKJQECTXPNISX-UHFFFAOYSA-N 0.000 claims 1
- WFZKROQHHVPSNR-UHFFFAOYSA-N 3-[4-[4-[(1,3-thiazol-2-ylamino)methyl]triazol-1-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(N2N=NC(CNC=3SC=CN=3)=C2)C=C1 WFZKROQHHVPSNR-UHFFFAOYSA-N 0.000 claims 1
- JMNXIBOAEXSEQX-UHFFFAOYSA-N 3-[4-[4-[(1h-benzimidazol-2-ylamino)methyl]triazol-1-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(N2N=NC(CNC=3NC4=CC=CC=C4N=3)=C2)C=C1 JMNXIBOAEXSEQX-UHFFFAOYSA-N 0.000 claims 1
- JMMWBNMECNXTQS-UHFFFAOYSA-N 3-[4-[4-[(1h-benzimidazol-2-ylamino)methyl]triazol-1-yl]phenyl]-2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(N2N=NC(CNC=3NC4=CC=CC=C4N=3)=C2)C=C1 JMMWBNMECNXTQS-UHFFFAOYSA-N 0.000 claims 1
- YFWUVUYSPUGDEW-UHFFFAOYSA-N 3-[4-[4-[(1h-imidazol-2-ylamino)methyl]-1,3-oxazol-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC=C(CNC=3NC=CN=3)N=2)C=C1 YFWUVUYSPUGDEW-UHFFFAOYSA-N 0.000 claims 1
- ZCGARPVOUXQJBC-UHFFFAOYSA-N 3-[4-[4-[(1h-imidazol-2-ylamino)methyl]-1,3-thiazol-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SC=C(CNC=3NC=CN=3)N=2)C=C1 ZCGARPVOUXQJBC-UHFFFAOYSA-N 0.000 claims 1
- KVUOYTFIUFODLR-UHFFFAOYSA-N 3-[4-[4-[(1h-imidazol-2-ylamino)methyl]-1h-pyrrol-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2NC=C(CNC=3NC=CN=3)C=2)C=C1 KVUOYTFIUFODLR-UHFFFAOYSA-N 0.000 claims 1
- HOTOKJWMPJEUHF-UHFFFAOYSA-N 3-[4-[4-[(1h-imidazol-2-ylamino)methyl]furan-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC=C(CNC=3NC=CN=3)C=2)C=C1 HOTOKJWMPJEUHF-UHFFFAOYSA-N 0.000 claims 1
- HEOQRFSBGFYRBL-UHFFFAOYSA-N 3-[4-[4-[(1h-imidazol-2-ylamino)methyl]imidazol-1-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(N2C=C(CNC=3NC=CN=3)N=C2)C=C1 HEOQRFSBGFYRBL-UHFFFAOYSA-N 0.000 claims 1
- QCFMPJYVRBILKS-UHFFFAOYSA-N 3-[4-[4-[(1h-imidazol-2-ylamino)methyl]pyrazol-1-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(N2N=CC(CNC=3NC=CN=3)=C2)C=C1 QCFMPJYVRBILKS-UHFFFAOYSA-N 0.000 claims 1
- IXFGACAXUIYRJN-UHFFFAOYSA-N 3-[4-[4-[(1h-imidazol-2-ylamino)methyl]thiophen-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SC=C(CNC=3NC=CN=3)C=2)C=C1 IXFGACAXUIYRJN-UHFFFAOYSA-N 0.000 claims 1
- CDGDJMLJPNGCEI-UHFFFAOYSA-N 3-[4-[4-[(1h-imidazol-2-ylamino)methyl]triazol-1-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(N2N=NC(CNC=3NC=CN=3)=C2)C=C1 CDGDJMLJPNGCEI-UHFFFAOYSA-N 0.000 claims 1
- VJZQVBCJWQXXRI-UHFFFAOYSA-N 3-[4-[4-[[(4-methoxypyridin-2-yl)amino]methyl]-1,3-oxazol-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound COC1=CC=NC(NCC=2N=C(OC=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 VJZQVBCJWQXXRI-UHFFFAOYSA-N 0.000 claims 1
- RWWOVLHCBSMPSV-UHFFFAOYSA-N 3-[4-[4-[[(4-methoxypyridin-2-yl)amino]methyl]-1,3-thiazol-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound COC1=CC=NC(NCC=2N=C(SC=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 RWWOVLHCBSMPSV-UHFFFAOYSA-N 0.000 claims 1
- FRSYATQBQPRMQJ-UHFFFAOYSA-N 3-[4-[4-[[(4-methoxypyridin-2-yl)amino]methyl]furan-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound COC1=CC=NC(NCC=2C=C(OC=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 FRSYATQBQPRMQJ-UHFFFAOYSA-N 0.000 claims 1
- OBHYTZGMDPWUTC-UHFFFAOYSA-N 3-[4-[4-[[(4-methoxypyridin-2-yl)amino]methyl]thiophen-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound COC1=CC=NC(NCC=2C=C(SC=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 OBHYTZGMDPWUTC-UHFFFAOYSA-N 0.000 claims 1
- FCRZQGFXLZHVOF-UHFFFAOYSA-N 3-[4-[4-[[(4-methoxypyridin-2-yl)amino]methyl]triazol-1-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound COC1=CC=NC(NCC=2N=NN(C=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 FCRZQGFXLZHVOF-UHFFFAOYSA-N 0.000 claims 1
- ORQUZRUVVNEMRL-UHFFFAOYSA-N 3-[4-[4-[[(4-methylpyridin-2-yl)amino]methyl]-1,3-oxazol-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC=NC(NCC=2N=C(OC=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 ORQUZRUVVNEMRL-UHFFFAOYSA-N 0.000 claims 1
- BXEINKWRIJRXNY-UHFFFAOYSA-N 3-[4-[4-[[(4-methylpyridin-2-yl)amino]methyl]-1,3-thiazol-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC=NC(NCC=2N=C(SC=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 BXEINKWRIJRXNY-UHFFFAOYSA-N 0.000 claims 1
- GNNSUMADLWATJP-UHFFFAOYSA-N 3-[4-[4-[[(4-methylpyridin-2-yl)amino]methyl]triazol-1-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC=NC(NCC=2N=NN(C=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 GNNSUMADLWATJP-UHFFFAOYSA-N 0.000 claims 1
- IBDNZGIQWNVEMX-UHFFFAOYSA-N 3-[4-[4-[[(5-methyl-1,3-thiazol-2-yl)amino]methyl]triazol-1-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound S1C(C)=CN=C1NCC1=CN(C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)N=N1 IBDNZGIQWNVEMX-UHFFFAOYSA-N 0.000 claims 1
- HNSVYCYTDHWVJJ-UHFFFAOYSA-N 3-[4-[5-[(1h-benzimidazol-2-ylamino)methyl]-1,2-thiazol-3-yl]phenyl]-2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C2=NSC(CNC=3NC4=CC=CC=C4N=3)=C2)C=C1 HNSVYCYTDHWVJJ-UHFFFAOYSA-N 0.000 claims 1
- UKHCDPZDYFZJKM-UHFFFAOYSA-N 3-[4-[5-[(1h-benzimidazol-2-ylamino)methyl]-1,3,4-oxadiazol-2-yl]phenyl]-2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC(CNC=3NC4=CC=CC=C4N=3)=NN=2)C=C1 UKHCDPZDYFZJKM-UHFFFAOYSA-N 0.000 claims 1
- UKVIJYSNQAONNJ-UHFFFAOYSA-N 3-[4-[5-[(1h-benzimidazol-2-ylamino)methyl]-1,3,4-thiadiazol-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SC(CNC=3NC4=CC=CC=C4N=3)=NN=2)C=C1 UKVIJYSNQAONNJ-UHFFFAOYSA-N 0.000 claims 1
- VMMKRKDDAVXUFP-UHFFFAOYSA-N 3-[4-[5-[(1h-benzimidazol-2-ylamino)methyl]-1h-1,2,4-triazol-3-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2NC(CNC=3NC4=CC=CC=C4N=3)=NN=2)C=C1 VMMKRKDDAVXUFP-UHFFFAOYSA-N 0.000 claims 1
- OFWAXJVULMIKQP-UHFFFAOYSA-N 3-[4-[5-[(1h-benzimidazol-2-ylamino)methyl]-1h-1,2,4-triazol-3-yl]phenyl]-2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2NC(CNC=3NC4=CC=CC=C4N=3)=NN=2)C=C1 OFWAXJVULMIKQP-UHFFFAOYSA-N 0.000 claims 1
- BALPINRAEVFSOF-UHFFFAOYSA-N 3-[4-[5-[(1h-benzimidazol-2-ylamino)methyl]furan-2-yl]phenyl]-2-[(2-ethyl-4-fluoro-6-methylbenzoyl)amino]propanoic acid Chemical compound CCC1=CC(F)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC(CNC=3NC4=CC=CC=C4N=3)=CC=2)C=C1 BALPINRAEVFSOF-UHFFFAOYSA-N 0.000 claims 1
- DXOPIBHYXDMGFE-UHFFFAOYSA-N 3-[4-[5-[(1h-imidazol-2-ylamino)methyl]-1,2-oxazol-3-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C2=NOC(CNC=3NC=CN=3)=C2)C=C1 DXOPIBHYXDMGFE-UHFFFAOYSA-N 0.000 claims 1
- RUCVLHRMUHBDGA-UHFFFAOYSA-N 3-[4-[5-[(1h-imidazol-2-ylamino)methyl]-1,2-thiazol-3-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C2=NSC(CNC=3NC=CN=3)=C2)C=C1 RUCVLHRMUHBDGA-UHFFFAOYSA-N 0.000 claims 1
- CDOZKRKTEZWLIH-UHFFFAOYSA-N 3-[4-[5-[(1h-imidazol-2-ylamino)methyl]-1,3-oxazol-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC(CNC=3NC=CN=3)=CN=2)C=C1 CDOZKRKTEZWLIH-UHFFFAOYSA-N 0.000 claims 1
- XMPPPLXUODHDBJ-UHFFFAOYSA-N 3-[4-[5-[(1h-imidazol-2-ylamino)methyl]-1,3-thiazol-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SC(CNC=3NC=CN=3)=CN=2)C=C1 XMPPPLXUODHDBJ-UHFFFAOYSA-N 0.000 claims 1
- LWYAHMJMMRICOC-UHFFFAOYSA-N 3-[4-[5-[(1h-imidazol-2-ylamino)methyl]-1h-1,2,4-triazol-3-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2NC(CNC=3NC=CN=3)=NN=2)C=C1 LWYAHMJMMRICOC-UHFFFAOYSA-N 0.000 claims 1
- ZRKLLNOLGCZISI-UHFFFAOYSA-N 3-[4-[5-[(1h-imidazol-2-ylamino)methyl]-1h-pyrrol-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2NC(CNC=3NC=CN=3)=CC=2)C=C1 ZRKLLNOLGCZISI-UHFFFAOYSA-N 0.000 claims 1
- WDPVYSAANGPKPC-UHFFFAOYSA-N 3-[4-[5-[(1h-imidazol-2-ylamino)methyl]-1h-pyrrol-3-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2C=C(CNC=3NC=CN=3)NC=2)C=C1 WDPVYSAANGPKPC-UHFFFAOYSA-N 0.000 claims 1
- ZPEKRPGXTNVATH-UHFFFAOYSA-N 3-[4-[5-[(1h-imidazol-2-ylamino)methyl]furan-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2OC(CNC=3NC=CN=3)=CC=2)C=C1 ZPEKRPGXTNVATH-UHFFFAOYSA-N 0.000 claims 1
- SPDALJSDUBCXSK-UHFFFAOYSA-N 3-[4-[5-[(1h-imidazol-2-ylamino)methyl]furan-3-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2C=C(CNC=3NC=CN=3)OC=2)C=C1 SPDALJSDUBCXSK-UHFFFAOYSA-N 0.000 claims 1
- CHMDAAGIQKRSAH-UHFFFAOYSA-N 3-[4-[5-[(1h-imidazol-2-ylamino)methyl]thiophen-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2SC(CNC=3NC=CN=3)=CC=2)C=C1 CHMDAAGIQKRSAH-UHFFFAOYSA-N 0.000 claims 1
- TZPPPRZIGXJFLA-UHFFFAOYSA-N 3-[4-[5-[(1h-imidazol-2-ylamino)methyl]thiophen-3-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC(C)=CC(C)=C1C(=O)NC(C(O)=O)CC1=CC=C(C=2C=C(CNC=3NC=CN=3)SC=2)C=C1 TZPPPRZIGXJFLA-UHFFFAOYSA-N 0.000 claims 1
- WVQNYZNZXJEREA-UHFFFAOYSA-N 3-[4-[5-[[(4-methoxypyridin-2-yl)amino]methyl]-1,2-thiazol-3-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound COC1=CC=NC(NCC=2SN=C(C=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 WVQNYZNZXJEREA-UHFFFAOYSA-N 0.000 claims 1
- QGMABSQQETYDRG-UHFFFAOYSA-N 3-[4-[5-[[(4-methoxypyridin-2-yl)amino]methyl]-1,3,4-oxadiazol-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound COC1=CC=NC(NCC=2OC(=NN=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 QGMABSQQETYDRG-UHFFFAOYSA-N 0.000 claims 1
- INSCSSUUHWJYDG-UHFFFAOYSA-N 3-[4-[5-[[(4-methoxypyridin-2-yl)amino]methyl]-1,3,4-thiadiazol-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound COC1=CC=NC(NCC=2SC(=NN=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 INSCSSUUHWJYDG-UHFFFAOYSA-N 0.000 claims 1
- UASWMRGZYWHENP-UHFFFAOYSA-N 3-[4-[5-[[(4-methoxypyridin-2-yl)amino]methyl]-1,3-oxazol-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound COC1=CC=NC(NCC=2OC(=NC=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 UASWMRGZYWHENP-UHFFFAOYSA-N 0.000 claims 1
- GUCFKBOMUPXYMZ-UHFFFAOYSA-N 3-[4-[5-[[(4-methoxypyridin-2-yl)amino]methyl]-1,3-thiazol-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound COC1=CC=NC(NCC=2SC(=NC=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 GUCFKBOMUPXYMZ-UHFFFAOYSA-N 0.000 claims 1
- PVBQOCZWVQDKCC-UHFFFAOYSA-N 3-[4-[5-[[(4-methoxypyridin-2-yl)amino]methyl]furan-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound COC1=CC=NC(NCC=2OC(=CC=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 PVBQOCZWVQDKCC-UHFFFAOYSA-N 0.000 claims 1
- BDCBOQYCSSWGOX-UHFFFAOYSA-N 3-[4-[5-[[(4-methoxypyridin-2-yl)amino]methyl]furan-3-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound COC1=CC=NC(NCC=2OC=C(C=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 BDCBOQYCSSWGOX-UHFFFAOYSA-N 0.000 claims 1
- DJPAQBKCCCOFGZ-UHFFFAOYSA-N 3-[4-[5-[[(4-methoxypyridin-2-yl)amino]methyl]thiophen-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound COC1=CC=NC(NCC=2SC(=CC=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 DJPAQBKCCCOFGZ-UHFFFAOYSA-N 0.000 claims 1
- VWZFHMMSENXEGG-UHFFFAOYSA-N 3-[4-[5-[[(4-methoxypyridin-2-yl)amino]methyl]thiophen-3-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound COC1=CC=NC(NCC=2SC=C(C=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 VWZFHMMSENXEGG-UHFFFAOYSA-N 0.000 claims 1
- MPTBIPZXIBERDN-UHFFFAOYSA-N 3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1,2-oxazol-3-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC=NC(NCC=2ON=C(C=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 MPTBIPZXIBERDN-UHFFFAOYSA-N 0.000 claims 1
- NZOYXBMBDAGSOM-UHFFFAOYSA-N 3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1,2-thiazol-3-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC=NC(NCC=2SN=C(C=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 NZOYXBMBDAGSOM-UHFFFAOYSA-N 0.000 claims 1
- NTIGIOPWXRLTPE-UHFFFAOYSA-N 3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1,3,4-thiadiazol-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC=NC(NCC=2SC(=NN=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 NTIGIOPWXRLTPE-UHFFFAOYSA-N 0.000 claims 1
- NGVSGKWUDLHMLV-UHFFFAOYSA-N 3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]-1,3-oxazol-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC=NC(NCC=2OC(=NC=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 NGVSGKWUDLHMLV-UHFFFAOYSA-N 0.000 claims 1
- PRAVEYDFLRFTLU-UHFFFAOYSA-N 3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]furan-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC=NC(NCC=2OC(=CC=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 PRAVEYDFLRFTLU-UHFFFAOYSA-N 0.000 claims 1
- FRPGBHHSSLLPBR-UHFFFAOYSA-N 3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]furan-3-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC=NC(NCC=2OC=C(C=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 FRPGBHHSSLLPBR-UHFFFAOYSA-N 0.000 claims 1
- JGLQVCIFIVNCDI-UHFFFAOYSA-N 3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]thiophen-2-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC=NC(NCC=2SC(=CC=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 JGLQVCIFIVNCDI-UHFFFAOYSA-N 0.000 claims 1
- NGTNKGZZBUCXGO-UHFFFAOYSA-N 3-[4-[5-[[(4-methylpyridin-2-yl)amino]methyl]thiophen-3-yl]phenyl]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid Chemical compound CC1=CC=NC(NCC=2SC=C(C=2)C=2C=CC(CC(NC(=O)C=3C(=CC(C)=CC=3C)C)C(O)=O)=CC=2)=C1 NGTNKGZZBUCXGO-UHFFFAOYSA-N 0.000 claims 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- UVZMZJUBRXCQCT-UHFFFAOYSA-N 4-chloro-2-ethyl-6-methylbenzamide Chemical compound CCC1=CC(Cl)=CC(C)=C1C(N)=O UVZMZJUBRXCQCT-UHFFFAOYSA-N 0.000 claims 1
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 claims 1
- 208000030507 AIDS Diseases 0.000 claims 1
- 208000032671 Allergic granulomatous angiitis Diseases 0.000 claims 1
- 206010002329 Aneurysm Diseases 0.000 claims 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 claims 1
- 206010003210 Arteriosclerosis Diseases 0.000 claims 1
- 206010003571 Astrocytoma Diseases 0.000 claims 1
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- 206010003694 Atrophy Diseases 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- 206010005003 Bladder cancer Diseases 0.000 claims 1
- 208000003174 Brain Neoplasms Diseases 0.000 claims 1
- 208000014644 Brain disease Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 201000009030 Carcinoma Diseases 0.000 claims 1
- 208000002177 Cataract Diseases 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 208000000668 Chronic Pancreatitis Diseases 0.000 claims 1
- 208000006344 Churg-Strauss Syndrome Diseases 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 206010010539 Congenital megacolon Diseases 0.000 claims 1
- 208000028006 Corneal injury Diseases 0.000 claims 1
- 206010011044 Corneal scar Diseases 0.000 claims 1
- 206010011091 Coronary artery thrombosis Diseases 0.000 claims 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 claims 1
- 208000001708 Dupuytren contracture Diseases 0.000 claims 1
- 208000018428 Eosinophilic granulomatosis with polyangiitis Diseases 0.000 claims 1
- 208000000571 Fibrocystic breast disease Diseases 0.000 claims 1
- 201000008808 Fibrosarcoma Diseases 0.000 claims 1
- 241000233866 Fungi Species 0.000 claims 1
- 206010017993 Gastrointestinal neoplasms Diseases 0.000 claims 1
- 208000007465 Giant cell arteritis Diseases 0.000 claims 1
- 208000010412 Glaucoma Diseases 0.000 claims 1
- 206010061431 Glial scar Diseases 0.000 claims 1
- 206010018341 Gliosis Diseases 0.000 claims 1
- 206010018691 Granuloma Diseases 0.000 claims 1
- 206010072579 Granulomatosis with polyangiitis Diseases 0.000 claims 1
- 208000003807 Graves Disease Diseases 0.000 claims 1
- 208000015023 Graves' disease Diseases 0.000 claims 1
- 206010019668 Hepatic fibrosis Diseases 0.000 claims 1
- 208000004592 Hirschsprung disease Diseases 0.000 claims 1
- 238000004566 IR spectroscopy Methods 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 208000029523 Interstitial Lung disease Diseases 0.000 claims 1
- 206010072877 Intestinal fibrosis Diseases 0.000 claims 1
- 208000003456 Juvenile Arthritis Diseases 0.000 claims 1
- 206010059176 Juvenile idiopathic arthritis Diseases 0.000 claims 1
- 208000011200 Kawasaki disease Diseases 0.000 claims 1
- 208000002260 Keloid Diseases 0.000 claims 1
- 206010023330 Keloid scar Diseases 0.000 claims 1
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 1
- 206010069698 Langerhans' cell histiocytosis Diseases 0.000 claims 1
- 206010024380 Leukoderma Diseases 0.000 claims 1
- 208000004852 Lung Injury Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 206010025323 Lymphomas Diseases 0.000 claims 1
- 206010027406 Mesothelioma Diseases 0.000 claims 1
- 208000016285 Movement disease Diseases 0.000 claims 1
- 208000010718 Multiple Organ Failure Diseases 0.000 claims 1
- 201000003793 Myelodysplastic syndrome Diseases 0.000 claims 1
- 201000007224 Myeloproliferative neoplasm Diseases 0.000 claims 1
- 206010028594 Myocardial fibrosis Diseases 0.000 claims 1
- 208000001738 Nervous System Trauma Diseases 0.000 claims 1
- 208000022873 Ocular disease Diseases 0.000 claims 1
- 208000001132 Osteoporosis Diseases 0.000 claims 1
- 201000000023 Osteosclerosis Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 206010033649 Pancreatitis chronic Diseases 0.000 claims 1
- 241001111421 Pannus Species 0.000 claims 1
- 208000034038 Pathologic Neovascularization Diseases 0.000 claims 1
- 241000721454 Pemphigus Species 0.000 claims 1
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 1
- 208000037062 Polyps Diseases 0.000 claims 1
- 206010036346 Posterior capsule opacification Diseases 0.000 claims 1
- 208000002158 Proliferative Vitreoretinopathy Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 201000002154 Pterygium Diseases 0.000 claims 1
- 206010037394 Pulmonary haemorrhage Diseases 0.000 claims 1
- 208000001647 Renal Insufficiency Diseases 0.000 claims 1
- 206010038389 Renal cancer Diseases 0.000 claims 1
- 206010038848 Retinal detachment Diseases 0.000 claims 1
- 206010038933 Retinopathy of prematurity Diseases 0.000 claims 1
- 206010038934 Retinopathy proliferative Diseases 0.000 claims 1
- 241001303601 Rosacea Species 0.000 claims 1
- 206010039491 Sarcoma Diseases 0.000 claims 1
- 208000021386 Sjogren Syndrome Diseases 0.000 claims 1
- 208000000453 Skin Neoplasms Diseases 0.000 claims 1
- 208000007107 Stomach Ulcer Diseases 0.000 claims 1
- 206010042742 Sympathetic ophthalmia Diseases 0.000 claims 1
- 206010051379 Systemic Inflammatory Response Syndrome Diseases 0.000 claims 1
- 201000009594 Systemic Scleroderma Diseases 0.000 claims 1
- 206010042953 Systemic sclerosis Diseases 0.000 claims 1
- 208000001106 Takayasu Arteritis Diseases 0.000 claims 1
- 208000024313 Testicular Neoplasms Diseases 0.000 claims 1
- 206010057644 Testis cancer Diseases 0.000 claims 1
- 208000000728 Thymus Neoplasms Diseases 0.000 claims 1
- 208000024770 Thyroid neoplasm Diseases 0.000 claims 1
- 208000026062 Tissue disease Diseases 0.000 claims 1
- 206010069363 Traumatic lung injury Diseases 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 1
- 206010046851 Uveitis Diseases 0.000 claims 1
- 206010047115 Vasculitis Diseases 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 206010052428 Wound Diseases 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 230000002159 abnormal effect Effects 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 201000005188 adrenal gland cancer Diseases 0.000 claims 1
- 208000024447 adrenal gland neoplasm Diseases 0.000 claims 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 claims 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 1
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims 1
- 125000003282 alkyl amino group Chemical group 0.000 claims 1
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 claims 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 1
- 125000004414 alkyl thio group Chemical group 0.000 claims 1
- 125000004682 aminothiocarbonyl group Chemical group NC(=S)* 0.000 claims 1
- 206010002022 amyloidosis Diseases 0.000 claims 1
- 238000011122 anti-angiogenic therapy Methods 0.000 claims 1
- 230000003510 anti-fibrotic effect Effects 0.000 claims 1
- 230000003388 anti-hormonal effect Effects 0.000 claims 1
- 238000011861 anti-inflammatory therapy Methods 0.000 claims 1
- 230000001028 anti-proliverative effect Effects 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims 1
- 208000011775 arteriosclerosis disease Diseases 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 230000037444 atrophy Effects 0.000 claims 1
- MNFORVFSTILPAW-UHFFFAOYSA-N azetidin-2-one Chemical compound O=C1CCN1 MNFORVFSTILPAW-UHFFFAOYSA-N 0.000 claims 1
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 claims 1
- 201000000053 blastoma Diseases 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000001124 body fluid Anatomy 0.000 claims 1
- 239000010839 body fluid Substances 0.000 claims 1
- 210000000988 bone and bone Anatomy 0.000 claims 1
- 208000011803 breast fibrocystic disease Diseases 0.000 claims 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 1
- 230000004663 cell proliferation Effects 0.000 claims 1
- 210000003169 central nervous system Anatomy 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000002512 chemotherapy Methods 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 230000007882 cirrhosis Effects 0.000 claims 1
- 208000019425 cirrhosis of liver Diseases 0.000 claims 1
- 208000008609 collagenous colitis Diseases 0.000 claims 1
- 238000002648 combination therapy Methods 0.000 claims 1
- 210000002808 connective tissue Anatomy 0.000 claims 1
- 208000002528 coronary thrombosis Diseases 0.000 claims 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 231100000433 cytotoxic Toxicity 0.000 claims 1
- 229940127089 cytotoxic agent Drugs 0.000 claims 1
- 231100000599 cytotoxic agent Toxicity 0.000 claims 1
- 230000001472 cytotoxic effect Effects 0.000 claims 1
- 239000002619 cytotoxin Substances 0.000 claims 1
- 201000001981 dermatomyositis Diseases 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 208000033679 diabetic kidney disease Diseases 0.000 claims 1
- 125000004663 dialkyl amino group Chemical group 0.000 claims 1
- 125000004473 dialkylaminocarbonyl group Chemical group 0.000 claims 1
- RAABOESOVLLHRU-UHFFFAOYSA-N diazene Chemical class N=N RAABOESOVLLHRU-UHFFFAOYSA-N 0.000 claims 1
- 229910000071 diazene Inorganic materials 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 125000006263 dimethyl aminosulfonyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])S(*)(=O)=O 0.000 claims 1
- 230000006806 disease prevention Effects 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000002500 effect on skin Effects 0.000 claims 1
- 201000008184 embryoma Diseases 0.000 claims 1
- 230000002124 endocrine Effects 0.000 claims 1
- 208000003401 eosinophilic granuloma Diseases 0.000 claims 1
- 208000024519 eye neoplasm Diseases 0.000 claims 1
- 206010016629 fibroma Diseases 0.000 claims 1
- 230000002496 gastric effect Effects 0.000 claims 1
- 201000005917 gastric ulcer Diseases 0.000 claims 1
- 208000009197 gingival hypertrophy Diseases 0.000 claims 1
- 208000007565 gingivitis Diseases 0.000 claims 1
- 208000005017 glioblastoma Diseases 0.000 claims 1
- 201000010536 head and neck cancer Diseases 0.000 claims 1
- 208000014829 head and neck neoplasm Diseases 0.000 claims 1
- 210000002216 heart Anatomy 0.000 claims 1
- 208000006454 hepatitis Diseases 0.000 claims 1
- 231100000283 hepatitis Toxicity 0.000 claims 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 claims 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 claims 1
- 230000002209 hydrophobic effect Effects 0.000 claims 1
- ORTFAQDWJHRMNX-UHFFFAOYSA-N hydroxidooxidocarbon(.) Chemical group O[C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-N 0.000 claims 1
- 206010020718 hyperplasia Diseases 0.000 claims 1
- 230000001969 hypertrophic effect Effects 0.000 claims 1
- 208000009322 hypertrophic pyloric stenosis Diseases 0.000 claims 1
- 238000002650 immunosuppressive therapy Methods 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 238000011503 in vivo imaging Methods 0.000 claims 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 claims 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 claims 1
- 230000000968 intestinal effect Effects 0.000 claims 1
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 1
- 208000012947 ischemia reperfusion injury Diseases 0.000 claims 1
- 210000001117 keloid Anatomy 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 claims 1
- 201000010982 kidney cancer Diseases 0.000 claims 1
- 208000017169 kidney disease Diseases 0.000 claims 1
- 201000006370 kidney failure Diseases 0.000 claims 1
- 208000032839 leukemia Diseases 0.000 claims 1
- 125000005647 linker group Chemical group 0.000 claims 1
- 239000002502 liposome Substances 0.000 claims 1
- 208000019423 liver disease Diseases 0.000 claims 1
- 238000004020 luminiscence type Methods 0.000 claims 1
- 210000004072 lung Anatomy 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 231100000515 lung injury Toxicity 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 238000002595 magnetic resonance imaging Methods 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 208000004840 megacolon Diseases 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 201000008265 mesangial proliferative glomerulonephritis Diseases 0.000 claims 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims 1
- 125000006261 methyl amino sulfonyl group Chemical group [H]N(C([H])([H])[H])S(*)(=O)=O 0.000 claims 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 claims 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 208000001725 mucocutaneous lymph node syndrome Diseases 0.000 claims 1
- 208000029744 multiple organ dysfunction syndrome Diseases 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 206010028417 myasthenia gravis Diseases 0.000 claims 1
- 206010028537 myelofibrosis Diseases 0.000 claims 1
- 201000000050 myeloid neoplasm Diseases 0.000 claims 1
- 208000010125 myocardial infarction Diseases 0.000 claims 1
- 208000031225 myocardial ischemia Diseases 0.000 claims 1
- YRCWSBFWGSYAJH-UHFFFAOYSA-N n-methyl-1,3-thiazol-4-amine Chemical compound CNC1=CSC=N1 YRCWSBFWGSYAJH-UHFFFAOYSA-N 0.000 claims 1
- HMMPCBAWTWYFLR-UHFFFAOYSA-N n-pyridin-2-ylpyridin-2-amine Chemical group C=1C=CC=NC=1NC1=CC=CC=N1 HMMPCBAWTWYFLR-UHFFFAOYSA-N 0.000 claims 1
- 230000001338 necrotic effect Effects 0.000 claims 1
- 208000021971 neovascular inflammatory vitreoretinopathy Diseases 0.000 claims 1
- 201000009925 nephrosclerosis Diseases 0.000 claims 1
- 208000028412 nervous system injury Diseases 0.000 claims 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 claims 1
- 201000008106 ocular cancer Diseases 0.000 claims 1
- 201000008968 osteosarcoma Diseases 0.000 claims 1
- 208000030346 palmar fibromatosis Diseases 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 201000001219 parotid gland cancer Diseases 0.000 claims 1
- 230000001575 pathological effect Effects 0.000 claims 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 claims 1
- 210000004303 peritoneum Anatomy 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 238000002428 photodynamic therapy Methods 0.000 claims 1
- 238000002600 positron emission tomography Methods 0.000 claims 1
- 230000002980 postoperative effect Effects 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 230000000750 progressive effect Effects 0.000 claims 1
- 230000002062 proliferating effect Effects 0.000 claims 1
- 230000035755 proliferation Effects 0.000 claims 1
- 201000007914 proliferative diabetic retinopathy Diseases 0.000 claims 1
- 230000006785 proliferative vitreoretinopathy Effects 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 208000005069 pulmonary fibrosis Diseases 0.000 claims 1
- 208000002815 pulmonary hypertension Diseases 0.000 claims 1
- 125000002098 pyridazinyl group Chemical group 0.000 claims 1
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 1
- 238000001959 radiotherapy Methods 0.000 claims 1
- 201000002793 renal fibrosis Diseases 0.000 claims 1
- 208000037803 restenosis Diseases 0.000 claims 1
- 230000004264 retinal detachment Effects 0.000 claims 1
- 201000004700 rosacea Diseases 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 231100000241 scar Toxicity 0.000 claims 1
- 230000036573 scar formation Effects 0.000 claims 1
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 201000000849 skin cancer Diseases 0.000 claims 1
- 208000017520 skin disease Diseases 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 210000005222 synovial tissue Anatomy 0.000 claims 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 1
- 206010043207 temporal arteritis Diseases 0.000 claims 1
- 208000001608 teratocarcinoma Diseases 0.000 claims 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 201000003120 testicular cancer Diseases 0.000 claims 1
- 230000003582 thrombocytopenic effect Effects 0.000 claims 1
- 201000002510 thyroid cancer Diseases 0.000 claims 1
- 238000003325 tomography Methods 0.000 claims 1
- 230000000472 traumatic effect Effects 0.000 claims 1
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 claims 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 1
- 125000001889 triflyl group Chemical group FC(F)(F)S(*)(=O)=O 0.000 claims 1
- 210000003932 urinary bladder Anatomy 0.000 claims 1
- 201000005112 urinary bladder cancer Diseases 0.000 claims 1
- 0 CC*Cc1c(*)cc(*)cc1 Chemical compound CC*Cc1c(*)cc(*)cc1 0.000 description 89
- MMBJFCSAANACFM-UHFFFAOYSA-N C(C1)C(CC2)C1C(CC1)C2C(C2)C1C(C1)C3C4C21C[IH]CC34 Chemical compound C(C1)C(CC2)C1C(CC1)C2C(C2)C1C(C1)C3C4C21C[IH]CC34 MMBJFCSAANACFM-UHFFFAOYSA-N 0.000 description 1
- RDYPWNWWOOIIGR-UHFFFAOYSA-N C(C1)C2C1(C1)C2C(CC2C3)C1C31C2[IH]C1 Chemical compound C(C1)C2C1(C1)C2C(CC2C3)C1C31C2[IH]C1 RDYPWNWWOOIIGR-UHFFFAOYSA-N 0.000 description 1
- MHYQPYXJECGQQX-UHFFFAOYSA-N C=C1NCCc2c1cccc2 Chemical compound C=C1NCCc2c1cccc2 MHYQPYXJECGQQX-UHFFFAOYSA-N 0.000 description 1
- XWWPGBDIALOVFT-UHFFFAOYSA-N CC(CC1)(C2C[Tl])C2C(C2)C1C1=C2C[IH]C1 Chemical compound CC(CC1)(C2C[Tl])C2C(C2)C1C1=C2C[IH]C1 XWWPGBDIALOVFT-UHFFFAOYSA-N 0.000 description 1
- SNXCWVVNWSXEDU-UHFFFAOYSA-N C[IH][Tl]1C2C(CC3)C3CC12 Chemical compound C[IH][Tl]1C2C(CC3)C3CC12 SNXCWVVNWSXEDU-UHFFFAOYSA-N 0.000 description 1
- TZOYXRMEFDYWDQ-UHFFFAOYSA-N O=C(CC1)Nc2c1cccc2 Chemical compound O=C(CC1)Nc2c1cccc2 TZOYXRMEFDYWDQ-UHFFFAOYSA-N 0.000 description 1
- GJEZPIAPRYPIKJ-UHFFFAOYSA-N O=C1NCC11CCCC1 Chemical compound O=C1NCC11CCCC1 GJEZPIAPRYPIKJ-UHFFFAOYSA-N 0.000 description 1
- OHUNVIZOWXKZPH-UHFFFAOYSA-N O=C1NCC11CCCCC1 Chemical compound O=C1NCC11CCCCC1 OHUNVIZOWXKZPH-UHFFFAOYSA-N 0.000 description 1
- QLBOURVDEBOSCJ-UHFFFAOYSA-N O=C1NCCC11CCCC1 Chemical compound O=C1NCCC11CCCC1 QLBOURVDEBOSCJ-UHFFFAOYSA-N 0.000 description 1
- UYZFAPXBVNFJFD-UHFFFAOYSA-N O=C1NCCC11CCCCC1 Chemical compound O=C1NCCC11CCCCC1 UYZFAPXBVNFJFD-UHFFFAOYSA-N 0.000 description 1
- ZZNUDFDVFCFNPA-UHFFFAOYSA-N O=C1NCCCC11CCCC1 Chemical compound O=C1NCCCC11CCCC1 ZZNUDFDVFCFNPA-UHFFFAOYSA-N 0.000 description 1
- KNPLIBPLMPTEQW-UHFFFAOYSA-N O=C1NCCCC11CCCCC1 Chemical compound O=C1NCCCC11CCCCC1 KNPLIBPLMPTEQW-UHFFFAOYSA-N 0.000 description 1
- PXZQEOJJUGGUIB-UHFFFAOYSA-N O=C1NCc2ccccc12 Chemical compound O=C1NCc2ccccc12 PXZQEOJJUGGUIB-UHFFFAOYSA-N 0.000 description 1
- JYGFTBXVXVMTGB-UHFFFAOYSA-N O=C1Nc2ccccc2C1 Chemical compound O=C1Nc2ccccc2C1 JYGFTBXVXVMTGB-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06009872 | 2006-05-12 | ||
| PCT/EP2007/004283 WO2007131764A2 (en) | 2006-05-12 | 2007-05-14 | New heterocyclic compounds for the inhibition of integrins and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009536961A JP2009536961A (ja) | 2009-10-22 |
| JP2009536961A5 true JP2009536961A5 (https=) | 2010-07-01 |
Family
ID=38564437
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009510340A Pending JP2009536961A (ja) | 2006-05-12 | 2007-05-14 | インテグリンを阻害する新規複素環化合物及びその使用 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8309735B2 (https=) |
| EP (1) | EP2024357A2 (https=) |
| JP (1) | JP2009536961A (https=) |
| KR (1) | KR20090017512A (https=) |
| CN (1) | CN101448818A (https=) |
| AR (1) | AR060901A1 (https=) |
| AU (1) | AU2007251756A1 (https=) |
| BR (1) | BRPI0711659A2 (https=) |
| CA (1) | CA2652101A1 (https=) |
| IL (1) | IL194946A0 (https=) |
| MX (1) | MX2008014345A (https=) |
| RU (1) | RU2008148943A (https=) |
| TW (1) | TW200811164A (https=) |
| WO (1) | WO2007131764A2 (https=) |
| ZA (1) | ZA200809074B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR059224A1 (es) | 2006-01-31 | 2008-03-19 | Jerini Ag | Compuestos para la inhibicion de integrinas y uso de estas |
| TW200811164A (en) | 2006-05-12 | 2008-03-01 | Jerini Ag | New heterocyclic compounds for the inhibition of integrins and use thereof |
| WO2008093064A1 (en) * | 2007-01-29 | 2008-08-07 | Astrazeneca Ab | L-ALANINE DERIVATIVES AS α5 BETA 1 ANTAGONISTS |
| WO2010062829A1 (en) * | 2008-11-28 | 2010-06-03 | Lexicon Pharmaceuticals, Inc. | Tryptophan hydroxylase inhibitors for treating osteoporosis |
| UA110924C2 (uk) * | 2009-08-05 | 2016-03-10 | Е. І. Дю Пон Де Немур Енд Компані | Мезоіонні пестициди |
| AU2010315190A1 (en) * | 2009-11-05 | 2012-05-10 | Lexicon Pharmaceuticals, Inc. | Tryptophan hydroxylase inhibitors for the treatment of cancer |
| WO2015048819A1 (en) | 2013-09-30 | 2015-04-02 | The Regents Of The University Of California | Anti-alphavbeta1 integrin compounds and methods |
| CN103588770B (zh) * | 2013-11-27 | 2016-08-17 | 武汉尚赛光电科技有限公司 | 1,2,4-噻二唑衍生物及其作为电致发光材料的应用 |
| CA2981371A1 (en) * | 2015-03-10 | 2016-09-15 | The Regents Of The University Of California | Anti-alphavbeta1 integrin inhibitors and methods of use |
| CN108794496B (zh) * | 2018-04-28 | 2020-04-24 | 北京施安泰医药技术开发有限公司 | 一类cdk抑制剂、其药物组合物、制备方法及用途 |
| EP3932912A4 (en) * | 2019-02-28 | 2022-09-07 | Osaka University | PROTEIN AND/OR PEPTIDE MODIFICATION MOLECULE |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4302051A1 (de) * | 1993-01-26 | 1994-07-28 | Thomae Gmbh Dr K | 5-gliedrige Heterocyclen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| EP0895475A4 (en) * | 1995-12-29 | 2000-08-23 | Smithkline Beecham Corp | VITRONECTIN RECEPTOR ANTAGONISTS |
| EP1017382B1 (en) * | 1997-05-29 | 2006-03-01 | Merck & Co., Inc. (a New Jersey corp.) | Biarylalkanoic acids as cell adhesion inhibitors |
| AU1411499A (en) * | 1997-11-20 | 1999-06-15 | Merck & Co., Inc. | Para-aminomethylaryl carboxamide derivatives |
| MY153569A (en) | 1998-01-20 | 2015-02-27 | Mitsubishi Tanabe Pharma Corp | Inhibitors of ?4 mediated cell adhesion |
| CZ20012185A3 (cs) * | 1998-12-16 | 2001-10-17 | Bayer Aktiengesellschaft | Nové bifenylové sloučeniny a sloučeniny analogické bifenylovým sloučeninám, způsob jejich přípravy, farmaceutické prostředky a pouľití těchto sloučenin a prostředků jako antagonistů integrinu |
| RU2270193C2 (ru) * | 1999-12-06 | 2006-02-20 | Ф.Хоффманн-Ля Рош Аг | 4-пиридинил-n-ацил-l-фенилаланины |
| US6388084B1 (en) * | 1999-12-06 | 2002-05-14 | Hoffmann-La Roche Inc. | 4-pyridinyl-n-acyl-l-phenylalanines |
| US6403584B1 (en) * | 2000-06-22 | 2002-06-11 | Merck & Co., Inc. | Substituted nipecotyl derivatives as inhibitors of cell adhesion |
| SK287781B6 (sk) * | 2000-08-18 | 2011-09-05 | Ajinomoto Co., Inc. | Fenylalanínové deriváty, farmaceutický prípravok s ich obsahom a ich použitie |
| JP4250423B2 (ja) * | 2001-03-19 | 2009-04-08 | 大日本住友製薬株式会社 | アリール置換脂環式化合物及びそれを含有する医薬組成物 |
| WO2003089410A1 (en) | 2002-04-19 | 2003-10-30 | Kyowa Hakko Kogyo Co., Ltd. | Phenylalanine derivative |
| AU2003278814A1 (en) * | 2002-09-13 | 2004-04-30 | Georgetown University | Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof |
| GB0329584D0 (en) | 2003-12-20 | 2004-01-28 | Tanabe Seiyaku Co | Novel compounds |
| KR20070004676A (ko) * | 2004-02-10 | 2007-01-09 | 얀센 파마슈티카 엔.브이. | 알파4 인테그린의 길항제로서의 피리다지논 |
| JP5032299B2 (ja) | 2004-03-24 | 2012-09-26 | シャイア・オーファン・セラピーズ・ゲーエムベーハー | 血管形成を阻害する新規化合物及びその使用 |
| BRPI0511099A (pt) * | 2004-05-14 | 2007-12-26 | Irm Llc | compostos e composições como moduladores de ppar |
| EP1954696B1 (en) * | 2005-01-19 | 2011-02-23 | Bristol-Myers Squibb Company | 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders |
| US8324265B2 (en) * | 2005-11-21 | 2012-12-04 | Shionogi & Co., Ltd. | Heterocyclic compounds having type I 11β hydroxysteroid dehydrogenase inhibitory activity |
| EP1957476A1 (en) | 2005-11-23 | 2008-08-20 | AstraZeneca AB | L-alanine derivatives |
| JP2009516729A (ja) * | 2005-11-23 | 2009-04-23 | アストラゼネカ アクチボラグ | L−フェニルアラニン誘導体 |
| AR059224A1 (es) * | 2006-01-31 | 2008-03-19 | Jerini Ag | Compuestos para la inhibicion de integrinas y uso de estas |
| TW200811164A (en) | 2006-05-12 | 2008-03-01 | Jerini Ag | New heterocyclic compounds for the inhibition of integrins and use thereof |
-
2007
- 2007-05-11 TW TW096116863A patent/TW200811164A/zh unknown
- 2007-05-11 AR ARP070102052A patent/AR060901A1/es not_active Application Discontinuation
- 2007-05-14 MX MX2008014345A patent/MX2008014345A/es not_active Application Discontinuation
- 2007-05-14 KR KR1020087027452A patent/KR20090017512A/ko not_active Withdrawn
- 2007-05-14 RU RU2008148943/04A patent/RU2008148943A/ru not_active Application Discontinuation
- 2007-05-14 WO PCT/EP2007/004283 patent/WO2007131764A2/en not_active Ceased
- 2007-05-14 BR BRPI0711659-4A patent/BRPI0711659A2/pt not_active IP Right Cessation
- 2007-05-14 US US12/300,530 patent/US8309735B2/en not_active Expired - Fee Related
- 2007-05-14 EP EP07725202A patent/EP2024357A2/en not_active Withdrawn
- 2007-05-14 CN CNA2007800171978A patent/CN101448818A/zh active Pending
- 2007-05-14 AU AU2007251756A patent/AU2007251756A1/en not_active Abandoned
- 2007-05-14 CA CA002652101A patent/CA2652101A1/en not_active Abandoned
- 2007-05-14 JP JP2009510340A patent/JP2009536961A/ja active Pending
-
2008
- 2008-10-22 ZA ZA200709074A patent/ZA200809074B/xx unknown
- 2008-10-27 IL IL194946A patent/IL194946A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009536961A5 (https=) | ||
| RU2008148943A (ru) | Новые гетероциклические соединения для ингибирования интегринов и их применение | |
| CA3087283C (en) | Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors | |
| RU2008135358A (ru) | Соединения для ингибирования интегриров и их применение | |
| CA2978823A1 (en) | Small molecule inhibitors of lactate dehydrogenase and methods of use thereof | |
| JP6028306B2 (ja) | トリヘテロ環式誘導体、調製方法及びそれらの使用 | |
| JP2022550297A (ja) | Sting(インターフェロン遺伝子刺激因子)のヘテロ多環式モジュレーター | |
| JP2008523041A5 (https=) | ||
| RU2010143319A (ru) | Бензопирановые и беноксепиновые ингибиторы рi3k и их применение | |
| JP2012515787A (ja) | 自己免疫疾患および炎症性疾患の処置におけるs1pアゴニストとしての置換オキサジアゾール誘導体 | |
| HRP20150642T1 (hr) | BICIKLIÄŚKE HETEROCIKLIÄŚKE TVARI KAO INHIBITORI FGFR-a | |
| JP2003535860A (ja) | 新規なオキサゾリジノン誘導体及びその製造方法 | |
| BRPI0720043A2 (pt) | Composto oxadiazol | |
| TW201038586A (en) | Sulfonamide derivatives | |
| KR102731925B1 (ko) | 파르네소이드 x 수용체 조정제로서의 멀티시클릭 화합물 | |
| PT1437349E (pt) | Isoxazóis substituídos e sua utilização como antibióticos | |
| WO2015148350A2 (en) | TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF | |
| IL285246B2 (en) | Substituted bicyclic compounds as farnesoid x receptor modulators | |
| JP2025515484A (ja) | Kif18aを阻害するための化合物 | |
| JP5602230B2 (ja) | スフィンゴシン−1−リン酸受容体アゴニスト | |
| AU728360B2 (en) | Thienylcyclohexanone derivatives as ligands of the gabaa alpha5 receptor subtype | |
| RU2014107000A (ru) | Производные 3-гетероароиламинопропионовой кислоты и их применение в качестве лекарственных средств | |
| BR112018016446B1 (pt) | Composto de piperidina halo-substituída, composição farmacêutica compreendendo dito composto e uso terapêutico dos mesmos | |
| CN103119038B (zh) | 作为1-磷酸鞘氨醇1受体激动剂的4-(5-异噁唑基或5-吡唑基-1,2,4-噁二唑基-3-基)扁桃酰胺 | |
| JPWO2019178129A5 (https=) |